<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Ginkgo biloba for tinnitus - Sereda, M - 2022 | Cochrane Library</title> <meta content="Ginkgo biloba for tinnitus - Sereda, M - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013514.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Ginkgo biloba for tinnitus - Sereda, M - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013514.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013514.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Ginkgo biloba for tinnitus" name="citation_title"/> <meta content="Magdalena Sereda" name="citation_author"/> <meta content="Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham" name="citation_author_institution"/> <meta content="magdalena.sereda@nottingham.ac.uk" name="citation_author_email"/> <meta content="Jun Xia" name="citation_author"/> <meta content="The University of Nottingham Ningbo" name="citation_author_institution"/> <meta content="Polly Scutt" name="citation_author"/> <meta content="Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham" name="citation_author_institution"/> <meta content="Malcolm P Hilton" name="citation_author"/> <meta content="Royal Devon and Exeter NHS Trust" name="citation_author_institution"/> <meta content="Amr El Refaie" name="citation_author"/> <meta content="University College Cork" name="citation_author_institution"/> <meta content="Derek J Hoare" name="citation_author"/> <meta content="Hearing Sciences, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD013514.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/11/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013514.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013514.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013514.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Ginkgo biloba; Headache; *Hypersensitivity; Randomized Controlled Trials as Topic; Seizures; *Tinnitus [therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013514.pub2&amp;doi=10.1002/14651858.CD013514.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013514\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013514\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ko","ms","ja","hr","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013514.pub2",title:"Ginkgo biloba for tinnitus",firstPublishedDate:"Nov 16, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane ENT Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013514.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013514.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013514.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013514.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013514.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013514.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013514.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013514.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013514.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013514.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9966 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013514.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0096"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0016"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-sec-0088"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/appendices#CD013514-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/supinfo/CD013514StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/supinfo/CD013514StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Ginkgo biloba for tinnitus</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Magdalena Sereda</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0005">Jun Xia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0006">Polly Scutt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0007">Malcolm P Hilton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0008">Amr El Refaie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information#CD013514-cr-0009">Derek J Hoare</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information/en#CD013514-sec-0107">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 November 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013514.pub2">https://doi.org/10.1002/14651858.CD013514.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013514-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013514-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013514-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013514-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013514-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013514-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013514-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013514-abs-0001" lang="en"> <section id="CD013514-sec-0001"> <h3 class="title" id="CD013514-sec-0001">Background</h3> <p>Tinnitus is a symptom defined as the perception of sound in the absence of an external source. In England alone there are an estimated ¾ million general practice consultations every year where the primary complaint is tinnitus, equating to a major burden on healthcare services. Clinical management strategies include education and advice, relaxation therapy, tinnitus retraining therapy (TRT), cognitive behavioural therapy (CBT), sound enrichment using ear‐level sound generators or hearing aids, and drug therapies to manage co‐morbid symptoms such as insomnia, anxiety or depression.  </p> </section> <section id="CD013514-sec-0002"> <h3 class="title" id="CD013514-sec-0002">Objectives</h3> <p>To assess the effects of Ginkgo biloba for tinnitus in adults and children.</p> </section> <section id="CD013514-sec-0003"> <h3 class="title" id="CD013514-sec-0003">Search methods</h3> <p>The Cochrane ENT Information Specialist searched the Cochrane ENT Register; CENTRAL (2022, Issue 6); Ovid MEDLINE; Ovid Embase; CINAHL; Web of Science; ClinicalTrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 7 June 2022. </p> </section> <section id="CD013514-sec-0004"> <h3 class="title" id="CD013514-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) recruiting adults and children with acute or chronic subjective tinnitus. We included studies where the intervention involved Ginkgo biloba and this was compared to placebo, no intervention, or education and information. Concurrent use of other medication or other treatment was acceptable if used equally in each group. Where an additional intervention was used equally in both groups, we analysed this as a separate comparison. The review included all courses of Ginkgo biloba, regardless of dose regimens or formulations, and for any duration of treatment<b>.</b> </p> </section> <section id="CD013514-sec-0005"> <h3 class="title" id="CD013514-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were tinnitus symptom severity measured as a global score on a multi‐item tinnitus questionnaire and serious adverse effects (bleeding, seizures). Our secondary outcomes were tinnitus loudness (change in subjective perception), tinnitus intrusiveness, generalised depression, generalised anxiety, health‐related quality of life and other adverse effects (gastrointestinal upset, headache, allergic reaction). We used GRADE to assess the certainty of the evidence for each outcome. </p> </section> <section id="CD013514-sec-0006"> <h3 class="title" id="CD013514-sec-0006">Main results</h3> <p>This review included 12 studies (with a total of  1915 participants). Eleven studies compared the effects of Ginkgo biloba with placebo and one study compared the effects of Ginkgo biloba with hearing aids to hearing aids alone. All included studies were parallel‐group RCTs. In general, risk of bias was high or unclear due to selection bias and poor reporting of allocation concealment and blinding of participants, personnel and outcome assessments. Due to heterogeneity in the outcomes measured and measurement methods used, only limited data pooling was possible.  </p> <p><b>Ginkgo biloba versus placebo</b> </p> <p>When we pooled data from two studies for the primary outcome tinnitus symptom severity, we found that Ginkgo biloba may have little to no effect (Tinnitus Handicap Inventory scores) at three to six months compared to placebo, but the evidence is very uncertain (mean difference (MD) ‐1.35 (scale 0 to 100), 95% confidence interval (CI) ‐8.26 to 5.55; 2 studies; 85 participants) (very low‐certainty). Ginkgo biloba may result in little to no difference in the risk of bleeding or seizures, with no serious adverse effects reported in either group (4 studies; 1154 participants; low‐certainty). </p> <p>For the secondary outcomes, one study found that there may be little to no difference between the effects of Ginkgo biloba and placebo on tinnitus loudness measured with audiometric loudness matching at 12 weeks, but the evidence is very uncertain (MD ‐4.00 (scale ‐10 to 140 dB), 95% CI ‐13.33 to 5.33; 1 study; 73 participants) (very low‐certainty). One study found that there may be little to no difference between the effects of Ginkgo biloba and placebo on health‐related quality of life measured with the Glasgow Health Status Inventory at three months (MD ‐0.58 (scale 0 to 100), 95% CI ‐4.67 to 3.51; 1 study; 60 participants) (low‐certainty). Ginkgo biloba may not increase the frequency of other adverse effects (gastrointestinal upset, headache, allergic reaction) at three months compared to placebo (risk ratio 0.91, 95% CI 0.52 to 1.60; 4 studies; 1175 participants) (low‐certainty). None of the studies reported the other secondary outcomes of tinnitus intrusiveness or changes in depressive symptoms or depression, anxiety symptoms or generalised anxiety. </p> <p><b>Gingko biloba with concurrent intervention versus concurrent intervention only</b> </p> <p>One study compared Ginkgo biloba with hearing aids to hearing aids only. It assessed the mean difference in the change in Tinnitus Handicap Inventory scores and tinnitus loudness using a 10‐point visual analogue scale (VAS) at three months. The study did not report adverse effects, tinnitus intrusiveness, changes in depressive symptoms or depression, anxiety symptoms or generalised anxiety, or health‐related quality of life. This was a single, very small study (22 participants) and for all outcomes the certainty of the evidence was very low. We were unable to draw meaningful conclusions from the numerical results. </p> </section> <section id="CD013514-sec-0007"> <h3 class="title" id="CD013514-sec-0007">Authors' conclusions</h3> <p>There is uncertainty about the benefits and harms of Ginkgo biloba for the treatment of tinnitus when compared to placebo. We were unable to draw meaningful conclusions regarding the benefits and harms of Ginkgo biloba when used with concurrent intervention (hearing aids). The certainty of the evidence for the reported outcomes, assessed using GRADE, ranged from low to very low. Future research into the effectiveness of Ginkgo biloba in patients with tinnitus should use rigorous methodology. Randomisation and blinding should be of the highest quality, given the subjective nature of tinnitus and the strong likelihood of a placebo response. The CONSORT statement should be used in the design and reporting of future studies. We also recommend the use of validated, patient‐centred outcome measures for research in the field of tinnitus. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013514-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013514-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD013514-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD013514-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013514-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013514-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013514-abs-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013514-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013514-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013514-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013514-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013514-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013514-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013514-abs-0002" lang="en"> <h3>Ginkgo biloba herbal supplement for tinnitus</h3> <p><b>What is tinnitus?</b> </p> <p>Tinnitus is a symptom where people have a perception of sound without there being an external source. It is often described as a ringing, hissing, buzzing or whooshing sound. It is common, affecting between 5% and 43% of the general population, and its prevalence increases with age. For some people tinnitus is persistent and troublesome, and it may lead to sleep problems (insomnia), difficulty concentrating, difficulties in communication and social interaction, and anxiety and depression. Management can include education and advice, relaxation therapy, tinnitus retraining therapy (TRT), cognitive behavioural therapy (CBT), sound generators or hearing aids, and drug therapies. The herbal supplement Ginkgo biloba has also been used. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out whether Ginkgo biloba reduces tinnitus severity and whether it has any unwanted or harmful effects. </p> <p><b>What did we do? </b> </p> <p>We searched for studies that looked at Ginkgo biloba compared to placebo ('dummy' treatment), no treatment or education/information alone in adults and children with tinnitus. We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as how the studies had been done and how many people were involved. </p> <p><b>What did we find? </b> </p> <p>We found 12 studies (with a total of 1915 people who participated). Eleven studies compared the effects of Ginkgo biloba with placebo. One study compared the effects of Ginkgo biloba combined with hearing aids to hearing aids alone. </p> <p><b>Main results </b> </p> <p>When we combined the results of two studies that measured tinnitus severity in the same way we found that Ginkgo biloba may have little to no effect compared to placebo, but the evidence is very uncertain. We looked at four studies that recorded any serious harmful effects, all of which reported none, so Ginkgo probably does not result in any difference in risk compared to placebo. However, the included studies did not look at the potentially harmful effects of Ginkgo biloba when used alongside other drugs. There may not be any difference between Ginkgo biloba and placebo in the effect on tinnitus loudness, but this is very uncertain. We also found that there may not be any difference in other outcomes (health‐related quality of life and minor unwanted effects such as gastrointestinal upset, headache and allergic reaction). There is no evidence to suggest that Ginkgo biloba has an effect on tinnitus when compared to placebo. </p> <p>We looked at the study that compared Ginkgo biloba combined with hearing aids to hearing aids alone. It assessed the difference in the change in tinnitus severity and loudness using a scale at three months. The study did not report any of the other outcomes we were interested in. This was a single, very small study (22 people) and the evidence was very uncertain. We were unable to draw meaningful conclusions from the findings of this study. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>Although we found 12 studies, half of them did not report outcomes that we were interested in. We were not able to combine the results from many of the remaining studies. We are not confident in the evidence for the effect on tinnitus severity of Ginkgo biloba compared to placebo. This is because some people dropped out of one study, only people over 60 were included, the studies were small and very few studies reported this important outcome. We have little confidence in the evidence about serious harmful effects because none were reported in either group and the studies may have had some problems in the way they were done. For tinnitus loudness we are not confident in the evidence because the study that measured this was very small, some people dropped out and only this one study reported this important outcome. We have little confidence in the evidence for health‐related quality of life and minor unwanted effects because the studies were small and may have had problems with the way they were done. </p> <p>We are not confident in the evidence for the effects of Ginkgo in combination with hearing aids because the number of participants in the study was very small. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is up to date to June 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013514-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013514-sec-0096"></div> <h3 class="title" id="CD013514-sec-0097">Implications for practice</h3> <section id="CD013514-sec-0097"> <p>Ginkgo biloba is commonly used as a food supplement for tinnitus and is also a popular first‐line treatment prescribed by general practitioners (GPs) and ENT physicians across Europe (<a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>). However, we did not find any evidence to support or refute the prescription of Ginkgo biloba for subjective tinnitus. There is uncertainty about the benefits and harms of Ginkgo biloba for the treatment of tinnitus when compared to placebo. The included studies did not investigate the potentially harmful interactions of Ginkgo biloba with other drugs (<a href="./references#CD013514-bbs2-0123" title="PosadzkiP , WatsonL , ErnstE . Herb-drug interaction: an overview of systematic reviews. British Journal of Clinical Pharmacology2012;75(3):603-18.">Posadzki 2012</a>).  </p> <p>In line with the lack of evidence for the effectiveness of Ginkgo biloba and potentially harmful interactions with other drugs, current tinnitus management guidelines recommend against its use for tinnitus treatment (<a href="./references#CD013514-bbs2-0047" title="CimaRFF , MazurekB , HaiderH , KikidisD , LapiraA , NoreñaA , et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO2019;67(Suppl 1):10-42.">Cima 2019</a>; <a href="./references#CD013514-bbs2-0149" title="TunkelDE , BauerCA , SunGH , RosenfeldRM , ChandrasekharSS , Cunningham ER Jr, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngology--Head and Neck Surgery2014;151(4):533-41.">Tunkel 2014</a>). The Multidisciplinary European Guideline for Tinnitus (<a href="./references#CD013514-bbs2-0047" title="CimaRFF , MazurekB , HaiderH , KikidisD , LapiraA , NoreñaA , et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO2019;67(Suppl 1):10-42.">Cima 2019</a>) based their recommendation on the results of several systematic reviews, which either concluded that Ginkgo biloba was not effective (<a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>), or highlighted the low methodological rigour of the included trials (<a href="./references#CD013514-bbs2-0153" title="vonBoetticherA . Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatric Disease and Treatment2011;7:441-7.">von Boetticher 2011</a>). The authors also highlighted that there was evidence that Ginkgo biloba can interact with other anticoagulant drugs to cause serious bleeding and worsen bleeding risk in patients with underlying clotting disorders (<a href="./references#CD013514-bbs2-0123" title="PosadzkiP , WatsonL , ErnstE . Herb-drug interaction: an overview of systematic reviews. British Journal of Clinical Pharmacology2012;75(3):603-18.">Posadzki 2012</a>). Similarly, the American Academy of Audiology Clinical Practice Guideline recommended against the use of Ginkgo biloba for treating patients with persistent, bothersome tinnitus (<a href="./references#CD013514-bbs2-0149" title="TunkelDE , BauerCA , SunGH , RosenfeldRM , ChandrasekharSS , Cunningham ER Jr, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngology--Head and Neck Surgery2014;151(4):533-41.">Tunkel 2014</a>). The above recommendation was based on variation in conclusions, methodological limitations and heterogeneity in the study protocols of the randomised controlled trials (RCTs) in addition to conflicting conclusions from systematic reviews. The guideline also referenced the evidence for serious side effects, which involve platelet inhibitory actions of Ginkgo biloba, particularly if taken along with other medications that impair coagulation (<a href="./references#CD013514-bbs2-0123" title="PosadzkiP , WatsonL , ErnstE . Herb-drug interaction: an overview of systematic reviews. British Journal of Clinical Pharmacology2012;75(3):603-18.">Posadzki 2012</a>), with the recommendation to avoid use of Ginkgo biloba in older adults, in which the use of anticoagulants and analgesics is widespread. Other mentioned herb‐drug interactions included thiazide diuretics, which resulted in increased blood pressure, and trazodone, which results in increased sedation (<a href="./references#CD013514-bbs2-0149" title="TunkelDE , BauerCA , SunGH , RosenfeldRM , ChandrasekharSS , Cunningham ER Jr, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngology--Head and Neck Surgery2014;151(4):533-41.">Tunkel 2014</a>). </p> <p>It is unlikely that the aetiology of tinnitus is the same for every tinnitus sufferer. Ginkgo biloba has been shown to affect vascular permeability and neuronal metabolism. If a greater level of understanding and diagnostic accuracy can be reached about the different aetiologies of tinnitus, this may naturally highlight subgroups of tinnitus patients in whom further controlled trials of Ginkgo biloba are worth considering. </p> </section> <h3 class="title" id="CD013514-sec-0098">Implications for research</h3> <section id="CD013514-sec-0098"> <p>Future research into the effectiveness of Ginkgo biloba in patients with tinnitus should use rigorous methodology. Randomisation and blinding should be of the highest quality, given the subjective nature of tinnitus and the strong likelihood of a placebo response. The CONSORT statement should be used in the design and reporting of future studies (<a href="./references#CD013514-bbs2-0049" title="SchulzKF , AltmanDG , MoherD , for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.">CONSORT 2010</a>). </p> <p>We also recommend the development of validated, patient‐centred outcome measures for research in the field of tinnitus. Visual analogue scales have limited value in this regard because quantifying change using only a single item has inadequate measurement properties (e.g. internal consistency cannot be established and test‐retest scores are at greater risk of instability). Only three out of 12 studies included in this review used multi‐item questionnaires of tinnitus symptom severity, and only one used a measure of heath‐related quality of life. Other outcomes such as depression and anxiety were not measured. Only four of the studies reported adverse effects. In future trials, multi‐item questionnaires of tinnitus symptom severity, validated instruments measuring depressive symptoms or depression, anxiety symptoms or generalised anxiety and health‐related quality of life should also be used.  </p> <p>Core outcome measures for adults with subjective tinnitus have been identified (<a href="./references#CD013514-bbs2-0073" title="HallDA , SmithH , HibbertA , ColleyV , HaiderHF , HorobinA , et al, Core Outcome Measures in Tinnitus (COMiT) initiative. The COMiT'ID Study: Developing core outcome domains sets for clinical trials of sound-, psychology-, and pharmacology-based interventions for chronic subjective tinnitus in adults. Trends in Hearing2018;22:2331216518814384.">Hall 2018a</a>). For pharmacological interventions, these are tinnitus intrusiveness and loudness. None of the included studies assessed tinnitus intrusiveness, and while loudness was assessed in two out of the five included studies, the measurement methods varied. There is no standard test for tinnitus loudness, and psychoacoustic loudness matching and subjective rating methods are equally common. These measurement methods are generally applied, and findings interpreted, with the assumption that they measure the same underlying construct (i.e. that they have convergent validity). However, retrospective analysis of one randomised placebo‐controlled trial in 91 participants with subjective idiopathic tinnitus indicates otherwise (<a href="./references#CD013514-bbs2-0071" title="HallDA , MehtaRL , FackrellK . How to choose between measures of tinnitus loudness for clinical research? A report on the reliability and validity of an investigator-administered test and a patient-reported measure using baseline data collected in a phase IIa drug trial. American Journal of Audiology2017;26(3):338-46.">Hall 2017</a>). Use of the core outcome set as a minimum standard for what should be assessed and reported in RCTs will facilitate comparison between studies and meta‐analyses (<a href="./references#CD013514-bbs2-0148" title="TunisSR , ClarkeM , GorstSL , GargonE , BlazebyJM , AltmanDG , et al. Improving the relevance and consistency of outcomes in comparative effectiveness research. Journal of Comparative Effectiveness Research2016;5(2):193-205.">Tunis 2016</a>). </p> <p>Given the heterogeneity of tinnitus patients, future trials should assess and report baseline characteristics so that the risk of potential confounding factors can be better understood. Examples include tinnitus duration, tinnitus symptom severity, age, hearing loss and co‐morbidities since these might reasonably modify treatment success. Future trials might also consider, as a subgroup analysis, the differential effect of Ginkgo biloba on acute (i.e. less than three months duration) versus chronic (more than three months duration) subjective idiopathic tinnitus. Individual participant characteristics were poorly described in the included studies. All studies included in the current review recruited chronic tinnitus patients (more than three months). Only three included studies performed a sample size estimation (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Future studies should seek to recruit an adequate sample size based on an appropriate power calculation for the primary outcome. </p> <p>It was not possible to address the question of the effectiveness of Ginkgo biloba for tinnitus associated with cognitive insufficiency as only two studies included such groups of patients (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>), with neither study including outcomes of interest to the current review, but it is a key area to consider for future development. Therefore, any future research into the effect of Ginkgo biloba on tinnitus must be careful to define its patient population with respect to cerebral function. It would be beneficial if further trials in cognitive insufficiency explicitly report the results for the subgroup of patients who have tinnitus at the outset of the study.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013514-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013514-sec-0008"></div> <div class="table" id="CD013514-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ginkgo biloba compared to placebo for tinnitus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Ginkgo biloba compared to placebo for tinnitus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> adults with tinnitus<br/><b>Setting: </b> departments of otorhinolaryngology in Brazil, Germany and Turkey and one study conducted by telephone/email<br/><b>Intervention:</b> Ginkgo biloba<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Ginkgo biloba</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus symptom severity </p> <p> </p> <p>Assessed with: THI (range: 0 to 100)</p> <p>Follow‐up: 3 to 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus symptom severity at 3 to 6 months was 4</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.35 lower<br/>(8.26 lower to 5.55 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may have little to no effect on tinnitus severity compared to placebo, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse effects (bleeding or seizures)</p> <p> </p> <p>Yes or no</p> <p>Follow‐up: at 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1154<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>5,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ginkgo biloba may result in little to no difference in the risk of serious adverse effects (bleeding or seizures), with zero cases reported in either group. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Zero events in the placebo group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Zero events in the Ginkgo biloba group</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus loudness</p> <p> </p> <p>Assessed with: audiometric loudness matching</p> <p>Follow‐up: at 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus loudness was 0.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4 lower<br/>(13.33 lower to 5.33 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>3,4,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may result in little to no difference in tinnitus loudness compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> <p> </p> <p>Assessed with: GHSI (range: 0 to 100)</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life at 3 months was 2.52</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.58 lower<br/>(4.67 lower to 3.51 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>3,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may result in little to no difference in quality of life compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Other adverse effects (gastrointestinal upset, headache, allergic reaction)</p> <p> </p> <p>Yes or no</p> <p>Follow‐up: at 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/>(0.52 to 1.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1175<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>3,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ginkgo biloba may not increase the frequency of other adverse effects (gastrointestinal upset, headache, allergic reaction) compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/>(21 to 66) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>GHSI:</b> Glasgow Health Status Inventory; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>THI:</b> Tinnitus Handicap Inventory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One of the two studies omitted primary outcome data, and had dropout without reason; downgraded by 0.5 level for study limitations. <br/><sup>2</sup>Only people over the age of 60 are included in this body of evidence; downgraded by 0.5 level for indirectness.<br/><sup>3</sup>Wide confidence interval around the point estimate; small sample size; downgraded by 1 level for imprecision. <br/><sup>4</sup>Only a small proportion of the included studies reported on this critical outcome: publication bias is suspected; downgraded by 1 level for publication bias. <br/><sup>5</sup>Some of the studies have multiple domains of unclear or high risk of bias; downgraded by 1 level for study limitations.<br/><sup>6</sup>There are no data regarding the primary outcome measure for 14 participants in the intervention group and 12 participants in the control group at 12 weeks. Dropout is not explained. Almost all of the bias domains are rated as either unclear or high risk; downgraded by 1 level for study limitations. <br/><sup>7</sup>Zero events in either group; downgraded by 1 level for imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013514-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gingko biloba with concurrent intervention versus concurrent intervention only</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Gingko biloba with concurrent intervention versus concurrent intervention only</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> adults with tinnitus<br/><b>Setting: </b> audiology centre in Brazil<br/><b>Intervention:</b> Ginkgo biloba plus hearing aids<br/><b>Comparison:</b> hearing aids </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hearing aids</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Ginkgo biloba plus hearing aids</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus symptom severity</p> <p> </p> <p>Assessed with: THI (range: 0 to 100)</p> <p>Follow‐up: at 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus symptom severity at 3 months was ‐40</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.5 higher<br/>(2.83 higher to 12.17 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When Ginkgo biloba was used in combination with hearing aids, the reduction in tinnitus symptom severity at 3 months was not as great as when hearing aids were used alone, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse effects (bleeding or seizures)</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not report serious adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus loudness</p> <p> </p> <p>Assessed with: 10‐point VAS (range: 0 to 10)</p> <p>Follow‐up: at 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus loudness at 3 months was ‐3.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1 higher<br/>(0.52 higher to 1.48 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When Ginkgo biloba was used in combination with hearing aids, the reduction in tinnitus loudness at 3 months was not as great as when hearing aids were used alone, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not include measures of health‐related quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse effects (gastrointestinal upset, headache, allergic reaction)</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not reported adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>SD:</b> standard deviation; <b>THI:</b> Tinnitus Handicap Inventory; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Not downgraded for indirectness, but it is worth noting that the study only included adult participants (mean age 56.3 years, SD 16.8 years).<br/><sup>2</sup>Very small sample size, below the requirement for optimal information size; downgraded by two levels for imprecision.<br/><sup>3</sup>Downgraded by one level for study limitations (high risk of bias) due to the lack of blinding during the conduct of the trial. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013514-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013514-sec-0009"></div> <p>This review supersedes the Cochrane Review 'Ginkgo biloba for tinnitus', which was first published in the <i>Cochrane Library</i> in Issue 3, 2013. The following paragraphs and <a href="#CD013514-sec-0010">Description of the condition</a> are based on the Cochrane Review 'Amplification with hearing aids for patients with tinnitus and co‐existing hearing loss' and are reproduced with permission (<a href="./references#CD013514-bbs2-0086" title="HoareDJ , Edmondson-JonesM , SeredaM , AkeroydMA , HallD . Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database of Systematic Reviews2014, Issue 1. Art. No: CD010151. [DOI: 10.1002/14651858.CD010151.pub2]">Hoare 2014</a>). <a href="#CD013514-sec-0013">Description of the intervention</a> and <a href="#CD013514-sec-0014">How the intervention might work</a> are based on the Cochrane Review 'Ginkgo biloba for tinnitus' and are reproduced with permission (<a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>). </p> <section id="CD013514-sec-0010"> <h3 class="title" id="CD013514-sec-0010">Description of the condition</h3> <p>Tinnitus is defined as the perception of sound in the absence of an external source (<a href="./references#CD013514-bbs2-0090" title="JastreboffPJ , HazellJWP . Tinnitus Retraining Therapy: Implementing the Neurophysiological Model. New York: Cambridge University Press, 2004.">Jastreboff 2004</a>). It is typically described by those who experience it as a ringing, hissing, buzzing or whooshing sound and is thought to result from abnormal neural activity at some point or points in the auditory pathway, which is erroneously interpreted by the brain as sound. Tinnitus can be either objective or subjective. Objective tinnitus refers to the perception of sound that can be also heard by the examiner and is usually due to turbulent blood flow or muscular contraction (<a href="./references#CD013514-bbs2-0130" title="RobertsLE , EggermontJJ , CasparyDM , ShoreSE , MelcherJR , KaltenbachJA . Ringing ears: the neuroscience of tinnitus. Journal of Neuroscience2010;30(45):14972-9.">Roberts 2010</a>). Most commonly, however, tinnitus is subjective; the sound is only heard by the person experiencing it and no source of the sound is identified (<a href="./references#CD013514-bbs2-0088" title="JastreboffPJ , BrennanJF , ColemanJK , SasakiCT . Phantom auditory sensation in rats: an animal model for tinnitus. Behavioral Neuroscience1988;102(6):811-22.">Jastreboff 1988</a>). Tinnitus affects between 5% and 43% of the general population and prevalence increases with age (<a href="./references#CD013514-bbs2-0103" title="McCormackA , Edmondson-JonesM , SomersetS , HallD . A systematic review of the reporting of tinnitus prevalence and severity. Hearing Research2016;337:70-9.">McCormack 2016</a>). It can be experienced acutely, recovering spontaneously within minutes to weeks, but is considered chronic and unlikely to resolve spontaneously when experienced for more than three months (<a href="./references#CD013514-bbs2-0068" title="GallusS , LugoA , GaravelloW , BosettiC , SantoroE , ColomboP , et al. Prevalence and determinants of tinnitus in the Italian adult population. Neuroepidemiology2015;45(1):12-9.">Gallus 2015</a>; <a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>). For many people tinnitus is persistent and troublesome, and has disabling effects such as insomnia, difficulty concentrating, difficulties in communication and social interaction, and negative emotional responses such as anxiety and depression (<a href="./references#CD013514-bbs2-0072" title="HallDA , FackrellK , LiAB , ThavayoganR , SmithS , KennedyV , et al. A narrative synthesis of research evidence for tinnitus-related complaints as reported by patients and their significant others. Health and Quality of Life Outcomes2018;16(1):61.">Hall 2018</a>). In approximately 90% of cases, chronic tinnitus is co‐morbid with some degree of measurable hearing loss, which may confound these disabling effects (<a href="./references#CD013514-bbs2-0066" title="FowlerEP . Head noises in normal and in disordered ears: significance, measurement, differentiation and treatment. Archives of Otolaryngology1944;39(6):498-503.">Fowler 1944</a>; <a href="./references#CD013514-bbs2-0132" title="SanchezTG , FerrariGMS . The control of tinnitus through hearing aids: suggestions for optimal use. Pró-Fono Revista de Atualização Científica2002;14:111-8.">Sanchez 2002</a>). Nevertheless, the association between hearing loss and tinnitus is not simple or straightforward; not all people with hearing loss experience tinnitus, and conversely some people with clinically normal hearing have tinnitus (<a href="./references#CD013514-bbs2-0034" title="BaguleyD , McFerranD , HallD . Tinnitus. Lancet2013;382(9904):1600-7.">Baguley 2013</a>). It has been reported that 40% of patients are unable to identify what health condition is associated with their tinnitus onset, i.e. the tinnitus is idiopathic (<a href="./references#CD013514-bbs2-0080" title="HenryJA , DennisKC , SchechterMA . General review of tinnitus: prevalence, mechanisms, effects, and management. Journal of Speech, Language, and Hearing Research2005;48(5):1204-35.">Henry 2005</a>). An important implication in clinical research is that outcome measures need to distinguish benefits specific to improved hearing from those specific to improvement in the psychological aspects of tinnitus. </p> <section id="CD013514-sec-0011"> <h4 class="title">Diagnosis and clinical management of tinnitus</h4> <p>There is no standard procedure for the diagnosis or management of tinnitus. Practice guidelines and the approaches described in studies of usual clinical practice typically reflect differences between the clinical specialisms of the authors or differences in the clinical specialisms charged with meeting tinnitus patients' needs (medical, audiology/hearing therapy, clinical psychology, psychiatry), or the available resources of a particular country or region (access to clinicians or devices, for example) (<a href="./references#CD013514-bbs2-0037" title="BiesingerE , Del BoL , De RidderD , GoodeyR , HerraizC , KleinjungT , et al. Algorithm for the diagnostic &amp; therapeutic management of tinnitus. Tinnitus Clinic Network, Tinnitus Research Initiative. Available at: www.tinnitus research.org/en/documents/downloads/TRI_Tinnitus_Flowchart.pdf (accessed 9 August 2010)2010.">Biesinger 2010</a>; <a href="./references#CD013514-bbs2-0046" title="CimaRF , MaesIH , JooreMA , ScheyenDJ , El RefaieA , BaguleyDM , et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet2012;379(9830):1951-9.">Cima 2012</a>; <a href="./references#CD013514-bbs2-0052" title="Department of Health. Provision of Services for Adults with Tinnitus. A Good Practice Guide. London: Central Office of Information, 2009.">Department of Health 2009</a>; <a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>; <a href="./references#CD013514-bbs2-0081" title="HenryJA , ZauggTL , MyersPJ , SchechterMA . The role of audiologic evaluation in progressive audiologic tinnitus management. Trends in Amplification2008;12(3):170-87.">Henry 2008</a>; <a href="./references#CD013514-bbs2-0085" title="HoareDJ , HallDA . Clinical guidelines and practice: a commentary on the complexity of tinnitus management. Evaluation &amp; the Health Professions2011;34(4):413-20.">Hoare 2011</a>). Common across all these documents, however, is the use or recommendation of written questionnaires to assess tinnitus and its impact on patients and their families by measuring tinnitus symptom severity (e.g. impact of tinnitus on quality of life, activities of daily living or sleep), and a judgement about patients who are experiencing a degree of psychological distress (depression or anxiety). Assessment of the perceptual characteristics of tinnitus (pitch, loudness, minimum masking level) and residual inhibition are also recommended (<a href="./references#CD013514-bbs2-0047" title="CimaRFF , MazurekB , HaiderH , KikidisD , LapiraA , NoreñaA , et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO2019;67(Suppl 1):10-42.">Cima 2019</a>). Although these measures do not correlate well with tinnitus symptom severity (<a href="./references#CD013514-bbs2-0083" title="HillerW , GoebelG . Factors influencing tinnitus loudness and annoyance. Archives of Otolaryngology-–Head &amp; Neck Surgery2006;132(12):1323-30.">Hiller 2006</a>), they can prove useful in patient counselling (<a href="./references#CD013514-bbs2-0079" title="HenryJA , Snow JB (editors). Tinnitus: Theory and Management. Ontario: BC Becker Inc, 2004.">Henry 2004</a>), as a baseline before start of treatment (<a href="./references#CD013514-bbs2-0060" title="El RefaieA , DavisA , KayanA , BaskillJ , LovellE , OwenV . A questionnaire study of the quality of life and quality of family life of individuals complaining of tinnitus pre- and post-attendance at a tinnitus clinic. International Journal of Audiology2004;43(7):410-6.">El Refaie 2004</a>), or by demonstrating stability of the tinnitus percept over time (<a href="./references#CD013514-bbs2-0052" title="Department of Health. Provision of Services for Adults with Tinnitus. A Good Practice Guide. London: Central Office of Information, 2009.">Department of Health 2009</a>). </p> <p>Clinical management strategies include education and advice, relaxation therapy, tinnitus retraining therapy (TRT), cognitive behavioural therapy (CBT), sound enrichment using ear‐level sound generators or hearing aids, and drug therapies to manage co‐morbid symptoms such as insomnia, anxiety or depression (for example, <a href="./references#CD013514-bbs2-0052" title="Department of Health. Provision of Services for Adults with Tinnitus. A Good Practice Guide. London: Central Office of Information, 2009.">Department of Health 2009</a>; <a href="./references#CD013514-bbs2-0149" title="TunkelDE , BauerCA , SunGH , RosenfeldRM , ChandrasekharSS , Cunningham ER Jr, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngology--Head and Neck Surgery2014;151(4):533-41.">Tunkel 2014</a>). As yet, no drug has been approved for tinnitus by a regulatory body (e.g. the European Medicines Agency or US Food and Drug Administration). </p> </section> <section id="CD013514-sec-0012"> <h4 class="title">Pathophysiology</h4> <p>Most people with chronic tinnitus have some degree of measurable hearing loss (<a href="./references#CD013514-bbs2-0125" title="RatnayakeSA , JayarajanV , BartlettJ . Could an underlying hearing loss be a significant factor in the handicap caused by tinnitus?Noise &amp; Health2009;11(44):156-60.">Ratnayake 2009</a>), and the prevalence of tinnitus increases with greater hearing loss (<a href="./references#CD013514-bbs2-0076" title="HanBI , LeeHW , KimTY , LimJS , ShinKS . Tinnitus: characteristics, causes, mechanisms, and treatments. Journal of Clinical Neurology2009;5(1):11-9.">Han 2009</a>; <a href="./references#CD013514-bbs2-0101" title="MartinesF , BentivegnaD , Di PiazzaF , MartinesE , SciaccaV , MartinciglioG . Investigation of tinnitus patients in Italy: clinical and audiological characteristics. International Journal of Otolaryngology2010;2010:265861.">Martines 2010</a>). The varying theories of tinnitus generation involve changes in either function or activity of the peripheral (cochlea and auditory nerve) or central auditory nervous systems (<a href="./references#CD013514-bbs2-0080" title="HenryJA , DennisKC , SchechterMA . General review of tinnitus: prevalence, mechanisms, effects, and management. Journal of Speech, Language, and Hearing Research2005;48(5):1204-35.">Henry 2005</a>). Theories involving the peripheral systems include the discordant damage theory, which predicts that the loss of outer hair cell function, where inner hair cell function is left intact, leads to a release from inhibition of inner hair cells and aberrant activity (typically hyperactivity) in the auditory nerve (<a href="./references#CD013514-bbs2-0089" title="JastreboffPJ . Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neuroscience Research1990;8(4):221-54.">Jastreboff 1990</a>). Such aberrant auditory nerve activity can also have a biochemical basis, resulting from excitotoxicity or stress‐induced enhancement of inner hair cell glutamate release with upregulation of N‐methyl‐D‐aspartate (NMDA) receptors (<a href="./references#CD013514-bbs2-0069" title="GuittonMJ , CastonJ , RuelJ , JohnsonRM , PujolR , PuelJL . Salicylate induces tinnitus through activation of cochlear NMDA receptors. Journal of Neuroscience2003;23(9):3944-52.">Guitton 2003</a>; <a href="./references#CD013514-bbs2-0131" title="SahleyTL , NodarRH . A biochemical model of peripheral tinnitus. Hearing Research2001;152(1-2):43-54.">Sahley 2001</a>). </p> <p>In the central auditory system, structures implicated as possible sites of tinnitus generation include the dorsal cochlear nucleus (<a href="./references#CD013514-bbs2-0109" title="MiddletonJW , KiritaniT , PedersenC , TurnerJG , ShepherdGM , TzounopoulosT . Mice with behavioral evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity because of decreased GABAergic inhibition. Proceedings of the National Academy of Sciences of the United States of America2011;108(18):7601-6.">Middleton 2011</a>; <a href="./references#CD013514-bbs2-0122" title="PilatiN , LargeC , ForsytheID , HamannM . Acoustic overexposure triggers burst firing in dorsal cochlear nucleus fusiform cells. Hearing Research2012;283(1-2):98-106.">Pilati 2012</a>), the inferior colliculus (<a href="./references#CD013514-bbs2-0057" title="DongS , RodgerJ , MuldersWH , RobertsonD . Tonotopic changes in GABA receptor expression in guinea pig inferior colliculus after partial unilateral hearing loss. Brain Research2010;1342:24-32.">Dong 2010</a>; <a href="./references#CD013514-bbs2-0113" title="MuldersWH , SeluakumaranK , RobertsonD . Efferent pathways modulate hyperactivity in inferior colliculus. Journal of Neuroscience2010;30(28):9578-87.">Mulders 2010</a>), and the auditory and non‐auditory cortex (discussed further below). There is a strong rationale that tinnitus is a direct consequence of maladaptive neuroplastic responses to hearing loss (<a href="./references#CD013514-bbs2-0110" title="MollerAR . Similarities between severe tinnitus and chronic pain. Journal of the American Academy of Audiology2000;11(3):115-24.">Moller 2000</a>; <a href="./references#CD013514-bbs2-0112" title="MuhlnickelW , ElbertT , TaubE , FlorH . Reorganization of auditory cortex in tinnitus. Proceedings of the National Academy of Sciences of the United States of America1998;95(17):10340-3.">Muhlnickel 1998</a>). This process is triggered by sensory deafferentation and a release from lateral inhibition in the central auditory system allowing irregular spontaneous hyperactivity within the central neuronal networks involved in sound processing (<a href="./references#CD013514-bbs2-0059" title="EggermontJJ , RobertsLE . The neuroscience of tinnitus. Trends in Neurosciences2004;27(11):676-82.">Eggermont 2004</a>; <a href="./references#CD013514-bbs2-0126" title="RauscheckerJP . Auditory cortical plasticity: a comparison with other sensory systems. Trends in Neurosciences1999;22(2):74-80.">Rauschecker 1999</a>; <a href="./references#CD013514-bbs2-0135" title="SekiS , EggermontJJ . Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hearing Research2003;180(1-2):28-38.">Seki 2003</a>). As a consequence of this hyperactivity, a further physiological change noted in tinnitus patients is increased spontaneous synchronous activity occurring at the subcortical and cortical level, measurable using electroencephalography (EEG) or magnetoencephalography (MEG) (<a href="./references#CD013514-bbs2-0055" title="DietrichV , NieschalkM , StollW , RajanR , PantevC . Cortical reorganization in patients with high frequency cochlear hearing loss. Hearing Research2001;158(1-2):95-101.">Dietrich 2001</a>; <a href="./references#CD013514-bbs2-0145" title="TassPA , AdamchicI , FreundHJ , vonStackelbergT , HauptmannC . Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restorative Neurology and Neuroscience2012;30(2):137-59.">Tass 2012</a>; <a href="./references#CD013514-bbs2-0154" title="WeiszN , MorattiS , MeinzerM , DohrmannK , ElbertT . Tinnitus perception and distress is related to abnormal spontaneous brain activity as measured by magnetoencephalography. PLOS Medicine2005;2(6):e153.">Weisz 2005</a>). Another physiological change thought to be involved in tinnitus generation is a process of functional reorganisation, which amounts to a change in the response properties of neurons within the primary auditory cortex to external sounds. This effect is well demonstrated physiologically in animal models of hearing loss (<a href="./references#CD013514-bbs2-0062" title="EngineerND , RileyJR , SealeJD , VranaWA , ShetakeJA , SudanaguntaSP , et al. Reversing pathological neural activity using targeted plasticity. Nature2011;470(7332):101-4.">Engineer 2011</a>; <a href="./references#CD013514-bbs2-0117" title="NorenaAJ , EggermontJJ . Enriched acoustic environment after noise trauma reduces hearing loss and prevents cortical map reorganization. Journal of Neuroscience2005;25(3):699-705.">Norena 2005</a>). Evidence in humans, however, is limited to behavioural evidence of cortical reorganisation after hearing loss, demonstrating improved frequency discrimination ability at the audiometric edge (<a href="./references#CD013514-bbs2-0092" title="KlukK , MooreBC . Dead regions in the cochlea and enhancement of frequency discrimination: effects of audiogram slope, unilateral versus bilateral loss, and hearing-aid use. Hearing Research2006;222(1-2):1-15.">Kluk 2006</a>; <a href="./references#CD013514-bbs2-0104" title="McDermottHJ , LechM , KornblumMS , IrvineDR . Loudness perception and frequency discrimination in subjects with steeply sloping hearing loss: possible correlates of neural plasticity. Journal of the Acoustical Society of America1998;104(4):2314-25.">McDermott 1998</a>; <a href="./references#CD013514-bbs2-0111" title="MooreBC , VinaySN . Enhanced discrimination of low-frequency sounds for subjects with high-frequency dead regions. Brain2009;132(Pt 2):524-36.">Moore 2009</a>; <a href="./references#CD013514-bbs2-0146" title="Thai-VanH , MicheylC , NorenaA , ColletL . Local improvement in auditory frequency discrimination is associated with hearing-loss slope in subjects with cochlear damage. Brain2002;125(Pt 3):524-37.">Thai‐Van 2002</a>; <a href="./references#CD013514-bbs2-0147" title="Thai-VanH , MicheylC , MooreBC , ColletL . Enhanced frequency discrimination near the hearing loss cut-off: a consequence of central auditory plasticity induced by cochlear damage?Brain2003;126(Pt 10):2235-45.">Thai‐Van 2003</a>), although <a href="./references#CD013514-bbs2-0043" title="BussE , HallJW , GroseJH , HatchDR . Perceptual consequences of peripheral hearing loss: do edge effects exist for abrupt cochlear lesions?Hearing Research1998;125(1-2):98-108.">Buss 1998</a> did not find this effect. For comprehensive reviews of these physiological models, see <a href="./references#CD013514-bbs2-0033" title="AdjamianP , SeredaM , HallDA . The mechanisms of tinnitus: perspectives from human functional neuroimaging. Hearing Research2009;253(1-2):15-31.">Adjamian 2009</a> and <a href="./references#CD013514-bbs2-0118" title="NorenaAJ . An integrative model of tinnitus based on a central gain controlling neural sensitivity. Neuroscience and Biobehavioral Reviews2011;35(5):1089-109.">Norena 2011</a>. </p> <p>It is also proposed that spontaneous hyperactivity could cause an increase in sensitivity or 'gain' at the level of the cortex, whereby neural sensitivity adapts to the reduced sensory inputs, in effect stabilising mean firing and neural coding efficiency (<a href="./references#CD013514-bbs2-0118" title="NorenaAJ . An integrative model of tinnitus based on a central gain controlling neural sensitivity. Neuroscience and Biobehavioral Reviews2011;35(5):1089-109.">Norena 2011</a>; <a href="./references#CD013514-bbs2-0133" title="SchaetteR , KempterR . Development of tinnitus-related neuronal hyperactivity through homeostatic plasticity after hearing loss: a computational model. European Journal of Neuroscience2006;23(11):3124-38.">Schaette 2006</a>; <a href="./references#CD013514-bbs2-0134" title="SchaetteR , McAlpineD . Tinnitus with a normal audiogram: physiological evidence for hidden hearing loss and computational model. Journal of Neuroscience2011;31(38):13452-7.">Schaette 2011</a>). Such adaptive changes would be achieved at the cost of amplifying 'neural noise' due to the overall increase in sensitivity, ultimately resulting in the generation of tinnitus. </p> <p>Increasingly, non‐auditory areas of the brain, particularly areas associated with emotional processing, are also implicated in bothersome tinnitus (<a href="./references#CD013514-bbs2-0127" title="RauscheckerJP , LeaverAM , MühlauM . Tuning out the noise: limbic-auditory interactions in tinnitus. Neuron2010;66(6):819-26.">Rauschecker 2010</a>; <a href="./references#CD013514-bbs2-0152" title="VannesteS , De RidderD . The auditory and non-auditory brain areas involved in tinnitus. An emergent property of multiple parallel overlapping subnetworks. Frontiers in Systems Neuroscience2012;6:31.">Vanneste 2012</a>). <a href="./references#CD013514-bbs2-0152" title="VannesteS , De RidderD . The auditory and non-auditory brain areas involved in tinnitus. An emergent property of multiple parallel overlapping subnetworks. Frontiers in Systems Neuroscience2012;6:31.">Vanneste 2012</a> describes tinnitus as "an emergent property of multiple parallel dynamically changing and partially overlapping sub‐networks", implicating the involvement of many structures of the brain more associated with memory and emotional processing in tinnitus generation. However, identification of the structural components of individual neural networks responsible for either tinnitus generation or tinnitus intrusiveness, which are independent of those for hearing loss, remains open to future research (<a href="./references#CD013514-bbs2-0108" title="MelcherJR , KnudsonIM , LevineRA . Subcallosal brain structure: correlation with hearing threshold at supra-clinical frequencies (&gt;8 kHz), but not with tinnitus. Hearing Research2013;295:79-86.">Melcher 2013</a>). One further complication in understanding the pathophysiology of tinnitus is that not all people with hearing loss have tinnitus and not all people with tinnitus have a clinically significant and measurable hearing loss. Other variables, such as the profile of a person's hearing loss, may account for differences in their tinnitus report. For example, <a href="./references#CD013514-bbs2-0094" title="KönigO , SchaetteR , KempterR , GrossM . Course of hearing loss and occurrence of tinnitus. Hearing Research2006;221:59-64.">König 2006</a> found that the maximum slope within audiograms was higher in people with tinnitus than in people with hearing loss who do not have tinnitus, despite the 'non‐tinnitus' group having the greater mean hearing loss. This suggests that a contrast in sensory inputs between regions of normal and elevated threshold may be more likely to result in tinnitus. However, this finding is not consistent across the literature (<a href="./references#CD013514-bbs2-0136" title="SeredaM , HallDA , BosnyakDJ , Edmondson-JonesM , RobertsLE , AdjamianP , et al. Re-examining the relationship between audiometric profile and tinnitus pitch. International Journal of Audiology2011;50(5):303-12.">Sereda 2011</a>; <a href="./references#CD013514-bbs2-0137" title="SeredaM , Edmondson-JonesM , HallDA . Relationship between tinnitus pitch and edge of hearing loss in individuals with a narrow tinnitus bandwidth. International Journal of Audiology2015;54(4):249-56.">Sereda 2015</a>). </p> </section> </section> <section id="CD013514-sec-0013"> <h3 class="title" id="CD013514-sec-0013">Description of the intervention</h3> <p>Extracts of Ginkgo biloba leaves have been used for medicinal purposes for at least 5000 years in China, where they form an important component of the traditional Chinese pharmacopoeia (a book which lists drugs and instructions for their use). More recently Ginkgo biloba extracts have been used in Western countries. In the USA, Canada and the UK extracts are widely available as non‐prescription food supplements (<a href="./references#CD013514-bbs2-0053" title="DiamondBJ , BaileyMR . Ginkgo biloba: indications, mechanisms, and safety. Psychiatric Clinics of North America2013;36(1):73-83.">Diamond 2013</a>; <a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>; <a href="./references#CD013514-bbs2-0151" title="UdeC , Schubert-ZsilaveczM , WurglicsM . Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clinical Pharmacokinetics2013;52(9):727-49.">Ude 2013</a>). In France and Germany a standardised dry leaf extract is registered as a drug and is commonly prescribed for tinnitus (<a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>; <a href="./references#CD013514-bbs2-0151" title="UdeC , Schubert-ZsilaveczM , WurglicsM . Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clinical Pharmacokinetics2013;52(9):727-49.">Ude 2013</a>). However, there are several components in the available Gingko biloba preparations. A purified and enriched liquid extract is prepared from dried leaves of the maidenhair plant. The liquid extract is dried to give one part extract from 50 raw leaves. The most important active chemical compounds are flavonoids (ginkgo‐flavone glycosides) and terpenoids (ginkgolides A, B, C, J and bilobalide). Ginkgolides appear to be unique to Ginkgo biloba and have not been isolated from any other plant species. Standardised Ginkgo leaf extracts have been used in clinical trials for tinnitus, and cognitive and cardiovascular disorders, at daily doses of 60 mg to 450 mg (<a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>; <a href="./references#CD013514-bbs2-0158" title="YangTH , YoungYH , LiuSH . EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. Journal of Nutritional Biochemistry2011;22(9):886-94.">Yang 2011</a>). These preparations contain standardised amounts of the above compounds. EGb761 (Tebonin, Tanakan, Rökan) contains 24% ginkgo‐flavone glycosides and 6% terpenoids, and LI 1370 (Kaveri) contains 25% ginkgo flavone glycosides and 6% terpenoids (<a href="./references#CD013514-bbs2-0040" title="BlumenthalM , BusseW , GoldbergA , GruenwaldJ , HallT , RigginsC . The Complete German Commission EMonographs: Therapeutic Guide to Herbal Medicines. Austin, Texas: American Botanical Council, 1998.">Blumenthal 1998</a>; <a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>). Although the quantities are standardised, the manufacturing process is different and the ratio of active ingredients within each sub‐class may be different. There is no standardisation for food supplement preparations (<a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>). </p> <p>The most commonly reported adverse effect of Ginkgo biloba is mild gastrointestinal disturbance (e.g. stomach pain, change in bowel habit). Serious adverse effects are rare, but include bleeding problems, interaction with anticoagulant medication and seizures (<a href="./references#CD013514-bbs2-0064" title="ErnstE . The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Annals of Internal Medicine2002;136:42-53.">Ernst 2002</a>; <a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>; <a href="./references#CD013514-bbs2-0124" title="RajarajanG , Pavithra PriyadorshoniSP , GeethaRV . A review on the medicinal properties of Gingko biloba. Drug Invention Today2018;10(3):3420-3.">Rajarajan 2018</a>). </p> </section> <section id="CD013514-sec-0014"> <h3 class="title" id="CD013514-sec-0014">How the intervention might work</h3> <p>Several mechanisms of action of Ginkgo biloba have been proposed in the light of its many active ingredients. Human, animal and in vitro studies indicate the following effects: </p> <p> <ul id="CD013514-list-0001"> <li> <p>A vasoregulatory effect (altering the tone of blood vessels) promoting increased blood flow (<a href="./references#CD013514-bbs2-0053" title="DiamondBJ , BaileyMR . Ginkgo biloba: indications, mechanisms, and safety. Psychiatric Clinics of North America2013;36(1):73-83.">Diamond 2013</a>; <a href="./references#CD013514-bbs2-0099" title="LichotaA , GwozdzinskiL , GwozdzinskiK . Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. European Journal of Medicinal Chemistry2019;176:68-91.">Lichota 2019</a>; <a href="./references#CD013514-bbs2-0119" title="NuhuAA . Ginkgo biloba: A ‘living fossil’ with modern day phytomedicinal applications. Journal of Applied Pharmaceutical Science2014;4(3):96-103.">Nuhu 2014</a>; <a href="./references#CD013514-bbs2-0138" title="ShuZ , SharAH , ShahenM , WangH , AlagawanyM , Abd El-HackME , et al. Pharmacological uses of Ginkgo biloba extracts for cardiovascular disease and coronary heart diseases. International Journal of Pharmacology2019;15:1-9.">Shu 2019</a>; <a href="./references#CD013514-bbs2-0156" title="XiaSH , FangDC . Pharmacological action and mechanisms of ginkgolide B. Chinese Medical Journal2007;120(10):922-8.">Xia 2007</a>; <a href="./references#CD013514-bbs2-0160" title="ZhouW , ChaiH , LinPH , LumsdenAB , YaoQ , ChenC . Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovascular Drug Reviews2004;22(4):309-19.">Zhou 2004</a>). Animal and human studies have shown that Ginkgo biloba can increase skin (<a href="./references#CD013514-bbs2-0041" title="BoelsmaE , LamersRJ , HendriksHF , vanNesselrooijJH , RozaL . Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans. Planta Medica2004;70(11):1052-7.">Boelsma 2004</a>; <a href="./references#CD013514-bbs2-0091" title="JungF , MrowietzC , KiesewetterH , WenzelE . Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung1990;40(5):589-93.">Jung 1990</a>; <a href="./references#CD013514-bbs2-0093" title="KoltringerP , EberO , KlimaG , RothlauerW , WakonigP , LangstegerW , et al. Microcirculation in parenteral Ginkgo biloba extract therapy [Die Mikrozirkulation unterparenteraler Ginkgo–biloba–Extrakt–Therapie]. WienerKlinische Wochenschrift1989;101(6):198-200.">Koltinger 1989</a>), cardiac (<a href="./references#CD013514-bbs2-0157" title="XiaoG , LyuM , WangY , HeS , LiuX , NiJ , et al. Ginkgo flavonol glycosides or ginkgolides tend to differentially protect myocardial or cerebral ischemia-reperfusion injury via regulation of TWEAK-Fn14 signaling in heart and brain. Frontiers in Pharmacology2019;10:735.">Xiao 2019</a>), and cerebral blood flow (<a href="./references#CD013514-bbs2-0098" title="LiMZ , ZhangY , ZouHY , OuyangJY , ZhanY , YangL , et al. Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis. Biomedicine &amp; Pharmacotherapy2018;103:989-1001.">Li 2018</a>; <a href="./references#CD013514-bbs2-0102" title="MashayekhA , PhamDL , YousemDM , DizonM , BarkerPB , LinDD . Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology2011;53(3):185-91.">Mashayekh 2011</a>). </p> </li> <li> <p>Antagonism of platelet activating factor (PAF) (<a href="./references#CD013514-bbs2-0053" title="DiamondBJ , BaileyMR . Ginkgo biloba: indications, mechanisms, and safety. Psychiatric Clinics of North America2013;36(1):73-83.">Diamond 2013</a>; <a href="./references#CD013514-bbs2-0115" title="NashKM , ShahZA . Current perspectives on the beneficial role of Ginkgo biloba in neurological and cerebrovascular disorders. Integrative Medicine Insights2015;10:1-9.">Nash 2015</a>; <a href="./references#CD013514-bbs2-0156" title="XiaSH , FangDC . Pharmacological action and mechanisms of ginkgolide B. Chinese Medical Journal2007;120(10):922-8.">Xia 2007</a>; <a href="./references#CD013514-bbs2-0160" title="ZhouW , ChaiH , LinPH , LumsdenAB , YaoQ , ChenC . Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovascular Drug Reviews2004;22(4):309-19.">Zhou 2004</a>). This effect is specific to the ginkgolides (predominantly B). PAF causes platelet (a blood constituent involved in blood clot formation) aggregation, neutrophil degranulation (activation of immune cells within the blood stream) and oxygen radical production. Ginkgolides appear to protect against the effects of hypoxic brain injury from cerebral ischaemia (permanent brain damage caused by insufficient blood and oxygen supply) in laboratory animals (<a href="./references#CD013514-bbs2-0042" title="BraquetP , HosfordD . Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. Journal of Ethnopharmacology1991;32(1-3):135-9.">Braquet 1991</a>; <a href="./references#CD013514-bbs2-0050" title="DeFeudisFV . Ginkgo biloba extract (EGb 761): pharmacological activities and clinical applications. Editions Scientifiques. In: Editions Scientifiques Elseviere. Elseviere, 1991:68-73.">DeFeudis 1991</a>; <a href="./references#CD013514-bbs2-0098" title="LiMZ , ZhangY , ZouHY , OuyangJY , ZhanY , YangL , et al. Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis. Biomedicine &amp; Pharmacotherapy2018;103:989-1001.">Li 2018</a>; <a href="./references#CD013514-bbs2-0141" title="SmithPF , MaclennanK , DarlingtonCL . The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). Journal of Ethnopharmacology1996;50(3):131-9.">Smith 1996</a>), and humans (<a href="./references#CD013514-bbs2-0121" title="OskoueiDS , RikhtegarR , HashemilarM , Sadeghi-BazarganiH , Sharifi-BonabM , Sadeghi-HokmabadiE , et al. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial. Journal of Stroke and Cerebrovascular Diseases2013;22(8):e557-63.">Oskouei 2013</a>). </p> </li> <li> <p>Antioxidant activity including scavenging of free radicals, indirectly inhibiting formation of free radicals, regulation of oxidative stress and anti‐lipid peroxidation (<a href="./references#CD013514-bbs2-0099" title="LichotaA , GwozdzinskiL , GwozdzinskiK . Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. European Journal of Medicinal Chemistry2019;176:68-91.">Lichota 2019</a>; <a href="./references#CD013514-bbs2-0100" title="MahadevanS , ParkY . Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. Journal of Food Science2008;73(1):R14-9.">Mahadevan 2008</a>; <a href="./references#CD013514-bbs2-0139" title="SinghSK , SrivastavS , CastellaniRJ , Plascencia-VillaG , PerryG . Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics2019;16(3):666-74.">Singh 2019</a>; <a href="./references#CD013514-bbs2-0160" title="ZhouW , ChaiH , LinPH , LumsdenAB , YaoQ , ChenC . Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovascular Drug Reviews2004;22(4):309-19.">Zhou 2004</a>; <a href="./references#CD013514-bbs2-0162" title="ZuoW , YanF , ZhangB , LiJ , MeiD . Advances in the studies of Ginkgo biloba leaves extract on aging-related diseases. Aging and Disease2017;8(6):812-26.">Zuo 2017</a>). </p> </li> <li> <p>Changes in the metabolism of neurons (<a href="./references#CD013514-bbs2-0039" title="Blecharz-KlinK , PiechalA , JoniecI , PyrzanowskaJ , Widy-TyszkiewiczE . Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiologiae Experimentalis2009;69(2):217-31.">Blecharz‐Klin 2009</a>; <a href="./references#CD013514-bbs2-0051" title="DeFeudisFV , DrieuK . Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Current Drug Targets2000;1(1):25-58.">DeFeudis 2000</a>; <a href="./references#CD013514-bbs2-0058" title="EckertA , KeilU , ScherpingI , HauptmannS , MüllerWE . Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Annals of the New York Academy of Sciences2005;1056:474-85.">Eckert 2005</a>), and restoration of age‐related deficiencies in central neurotransmitter systems (<a href="./references#CD013514-bbs2-0039" title="Blecharz-KlinK , PiechalA , JoniecI , PyrzanowskaJ , Widy-TyszkiewiczE . Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiologiae Experimentalis2009;69(2):217-31.">Blecharz‐Klin 2009</a>; <a href="./references#CD013514-bbs2-0051" title="DeFeudisFV , DrieuK . Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Current Drug Targets2000;1(1):25-58.">DeFeudis 2000</a>; <a href="./references#CD013514-bbs2-0065" title="FehskeCJ , LeunerK , MüllerWE . Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacological Research2009;60(1):68-73.">Fehske 2009</a>). </p> </li> <li> <p>Enhancement of neuronal plasticity including increased long‐term potentiation, spine density, neuritogenesis and neurogenesis, as shown in pre‐clinical reports (<a href="./references#CD013514-bbs2-0114" title="MüllerWE , HeiserJ , LeunerK . Effects of the standardized Ginkgo biloba extract EGb 761® on neuroplasticity. International Psychogeriatrics2012;Suppl 1:S21-4.">Müller 2012</a>). </p> </li> <li> <p>Anti‐inflammatory effects and protective actions against brain damage, possibly through its terpenoids and ginkgolides (<a href="./references#CD013514-bbs2-0045" title="ChengSM , YangSP , HoLJ , TsaoTP , JuanTY , ChangDM , et al. Down-regulation of c-jun N-terminal kinase-activator protein-1 signalling pathway by Ginkgo biloba extract in human peripheral blood T cells. Biochemical Pharmacology2003;66(4):679-89.">Cheng 2003</a>; <a href="./references#CD013514-bbs2-0099" title="LichotaA , GwozdzinskiL , GwozdzinskiK . Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. European Journal of Medicinal Chemistry2019;176:68-91.">Lichota 2019</a>; <a href="./references#CD013514-bbs2-0119" title="NuhuAA . Ginkgo biloba: A ‘living fossil’ with modern day phytomedicinal applications. Journal of Applied Pharmaceutical Science2014;4(3):96-103.">Nuhu 2014</a>; <a href="./references#CD013514-bbs2-0138" title="ShuZ , SharAH , ShahenM , WangH , AlagawanyM , Abd El-HackME , et al. Pharmacological uses of Ginkgo biloba extracts for cardiovascular disease and coronary heart diseases. International Journal of Pharmacology2019;15:1-9.">Shu 2019</a>; <a href="./references#CD013514-bbs2-0156" title="XiaSH , FangDC . Pharmacological action and mechanisms of ginkgolide B. Chinese Medical Journal2007;120(10):922-8.">Xia 2007</a>; <a href="./references#CD013514-bbs2-0159" title="ZhangW , TaoQ , GuoZ , FuY , ChenX , SharPA , et al. Systems pharmacology dissection of the integrated treatment for cardiovascular and gastrointestinal disorders by traditional Chinese medicine. Scientific Reports2016;6:32400.">Zhang 2016</a>). The Ginkgo biloba leaf extract has been shown to reduce the level of cytokines and inflammatory factors such as tumour necrosis factor alpha (TNF‐α), interleukin 6 (Il‐6), interleukin 1 beta (Il 1‐β) and matrix metalloproteinase 9 (<a href="./references#CD013514-bbs2-0120" title="OmidkhodaSF , RazaviBM , HosseinzadehH . Protective effects of Ginkgo biloba L. against natural toxins, chemical toxicities, and radiation: a comprehensive review. Phytotherapy Research 2019 Aug 19 [Epub ahead of print]. [DOI: 10.1002/ptr.6469]">Omidkhoda 2019</a>; <a href="./references#CD013514-bbs2-0159" title="ZhangW , TaoQ , GuoZ , FuY , ChenX , SharPA , et al. Systems pharmacology dissection of the integrated treatment for cardiovascular and gastrointestinal disorders by traditional Chinese medicine. Scientific Reports2016;6:32400.">Zhang 2016</a>). </p> </li> </ul> </p> <p>These mechanisms may treat tinnitus by preventing free‐radical damage to the cochlea, or increasing blood flow, improving the health of the inner ear (<a href="./references#CD013514-bbs2-0054" title="DidierA , Droy-LefaixMT , AurousseauC , CazalsY . Effects of Ginkgo biloba extract (EGb 761) on cochlear vasculature in the guinea pig: morphometric measurements and laser Doppler flowmetry. European Archives of Oto-rhino-laryngology1996;253(1-2):25-30.">Didier 1996</a>; <a href="./references#CD013514-bbs2-0142" title="SmithGS , Romanelli-GobbiM , Gray-KaragrigoriouE , ArtzGJ . Complementary and integrative treatments: tinnitus. Otolaryngologic Clinics of North America2013;46:389-408.">Smith 2013</a>). <a href="./references#CD013514-bbs2-0150" title="TziridisK , KornS , AhlfS , SchulzeH . Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development. Neural Plasticity2014;2014:427298. [DOI: 10.1155/2014/427298]">Tziridis 2014</a> tested the effectiveness of prophylactic treatment with EGb 761 for noise‐induced hearing loss and development of tinnitus after noise trauma in an animal model. Based on the results they suggested significant neuroplastic effects of EGb 761 on auditory processing at the peripheral and central level of the auditory pathway as measured with behavioural and electrophysiological approaches. They proposed a model of the effects of EGb 761 on auditory processing with two main effects: 1) an increase in auditory brainstem activity leading to an increased thalamic input to the primary auditory cortex; and 2) an asymmetric effect on lateral inhibition in the primary auditory cortex. </p> <p>A study by <a href="./references#CD013514-bbs2-0096" title="KraussP , TziridisK , BuerbankS , SchillingA , SchulzeH . Therapeutic value of Ginkgo biloba extract EGb 761® in an animal model (Meriones unguiculatus) for noise trauma induced hearing loss and tinnitus. PLOS One2016;11(6):e0157574.">Krauss 2016</a> examined the therapeutic effects of EGb 761 after the formation of permanent noise‐induced hearing loss and tinnitus in an animal model. They found that treatment with EGb 761 led to recovery of auditory thresholds and reduced behavioural signs of tinnitus. Interestingly, while the auditory thresholds were maintained, behavioural signs of tinnitus reappeared after discontinuation of treatment. An analysis of the auditory brainstem responses (ABRs) showed changes in ABR wave amplitude and latency at different levels of the auditory pathway (increase of response to low stimulus intensities and decrease at high intensities) rather than restoration of the auditory processing back to pre‐trauma conditions. Based on that result, the authors suggested a global inhibitory mechanism that counteracts tinnitus. The EGb 761 extract was also shown to protect against noise‐induced hearing loss by inhibiting the expression of proinflammatory cytokines and cyclooxygenase 2 (COX‐2), and increasing values of heat shock proteins in the rat cochlea (<a href="./references#CD013514-bbs2-0056" title="DoganR , SjostrandAP , YenıgunA , KaratasE , KocyigitA , OzturanO . Influence of Ginkgo Biloba extract (EGb 761) on expression of IL-1 beta, IL-6, TNF-alfa, HSP-70, HSF-1 and COX-2 after noise exposure in the rat cochlea. Auris Nasus Larynx2018;45(4):680-5.">Dogan 2018</a>). It was also shown to protect against cisplatin‐ and gentamicin‐induced hair cell loss, and subsequent changes in brain activity in animal models (<a href="./references#CD013514-bbs2-0087" title="HuangX , WhitworthCA , RybakLP . Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otology and Neurotology2007;28(6):828-33.">Huang 2007</a>; <a href="./references#CD013514-bbs2-0158" title="YangTH , YoungYH , LiuSH . EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis. Journal of Nutritional Biochemistry2011;22(9):886-94.">Yang 2011</a>). </p> </section> <section id="CD013514-sec-0015"> <h3 class="title" id="CD013514-sec-0015">Why it is important to do this review</h3> <p>In England alone there are an estimated ¾ million general practice consultations every year where the primary complaint is tinnitus (<a href="./references#CD013514-bbs2-0061" title="El-ShunnarSK , HoareDJ , SmithS , GanderPE , KangS , FackrellK , et al. Primary care for tinnitus: practice and opinion among GPs in England. Journal of Evaluation in Clinical Practice2011;17(4):684-92.">El Shunnar 2011</a>), equating to a major burden on healthcare services. Use of Gingko biloba for tinnitus is currently recommended against in the European tinnitus guideline (<a href="./references#CD013514-bbs2-0047" title="CimaRFF , MazurekB , HaiderH , KikidisD , LapiraA , NoreñaA , et al. A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment. HNO2019;67(Suppl 1):10-42.">Cima 2019</a>) and the American Academy of Otolaryngology Clinical Practice Guideline (<a href="./references#CD013514-bbs2-0149" title="TunkelDE , BauerCA , SunGH , RosenfeldRM , ChandrasekharSS , Cunningham ER Jr, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngology--Head and Neck Surgery2014;151(4):533-41.">Tunkel 2014</a>). Both guidelines conclude that there is no proven efficacy of Gingko biloba and that there is potential for harm. There is evidence that Ginkgo biloba interacts with antithrombotic drugs to cause serious bleeding and increases bleeding risk in clotting disorders (<a href="./references#CD013514-bbs2-0123" title="PosadzkiP , WatsonL , ErnstE . Herb-drug interaction: an overview of systematic reviews. British Journal of Clinical Pharmacology2012;75(3):603-18.">Posadzki 2012</a>). A worldwide survey of dietary supplements used to treat tinnitus reported that Ginkgo biloba was the most cited supplement resulting in adverse effects (diarrhoea, nausea, hearing, dizziness, headache, bleeding, blood pressure changes, chest pain, palpitation and increased urination) (<a href="./references#CD013514-bbs2-0048" title="CoelhoC , TylerR , JiH , Rojas-RoncancioE , WittS , TaoP , et al. Survey of effectiveness of dietary supplements to treat tinnitus. American Journal of Audiology2016;25:184-205.">Coelho 2016</a>). Despite this, Ginkgo biloba is commonly used for tinnitus (<a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>). A survey of treatment options for subjective tinnitus showed that Ginkgo biloba was a popular first‐line treatment prescribed by general practitioners (GPs) and ENT physicians across Europe, with a proportion of patients prescribed Ginkgo biloba as high as 71% in some countries (<a href="./references#CD013514-bbs2-0070" title="HallDA , LainezMJ , NewmanCW , SanchezTG , EglerM , TennigkeitF , et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Services Research2011;11:302.">Hall 2011</a>). Ginkgo biloba is freely available for purchase in health food stores across Europe and America (<a href="./references#CD013514-bbs2-0044" title="ChanPC , XiaQ , FuPP . Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2007;25(3):211-44.">Chan 2007</a>). A recent survey showed that 1 in 10 people with tinnitus in the UK use alternative therapies, including Gingko biloba (<a href="./references#CD013514-bbs2-0105" title="McFerranD , HoareDJ , CarrS , RayJ , StockdaleD . Tinnitus services in the United Kingdom: a survey of patient experiences. BMC Health Services Research2018;18:110.">McFerran 2018</a>). </p> <p>The previous Cochrane Review on this question concluded that there was no evidence that Gingko biloba was effective in patients with a primary complaint of tinnitus (<a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>). However, the methods and searches used in that review now require updating. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013514-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013514-sec-0016"></div> <p>To assess the effects of Ginkgo biloba for tinnitus in adults and children.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013514-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013514-sec-0017"></div> <section id="CD013514-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013514-sec-0019"> <h4 class="title">Types of studies</h4> <p>We included studies with following design characteristics:</p> <p> <ul id="CD013514-list-0002"> <li> <p>randomised controlled trials, including cluster‐randomised (cross‐over trials were eligible if data from before the cross‐over could be extracted, to avoid the potential for a carry‐over phenomenon). </p> </li> </ul> </p> <p>We excluded studies with the following design characteristics:</p> <p> <ul id="CD013514-list-0003"> <li> <p>quasi‐randomised controlled studies.</p> </li> </ul> </p> <p>We applied no restrictions on language, year of publication or publication status.</p> </section> <section id="CD013514-sec-0020"> <h4 class="title">Types of participants</h4> <p>Adults and children with acute (≤ 3 months) or chronic (&gt; 3 months) subjective tinnitus.</p> </section> <section id="CD013514-sec-0021"> <h4 class="title">Types of interventions</h4> <p>The review included all courses of Ginkgo biloba, regardless of dose regimens or formulations, and for any duration of treatment<b>.</b> </p> <p>The main comparison was:</p> <p> <ul id="CD013514-list-0004"> <li> <p>Ginkgo biloba versus placebo.</p> </li> </ul> </p> <p>Other possible comparison pairs included:</p> <p> <ul id="CD013514-list-0005"> <li> <p>Ginkgo biloba versus no intervention;</p> </li> <li> <p>Ginkgo biloba versus education and information only.</p> </li> </ul> </p> <p>Concurrent use of other medication or other treatment was acceptable if used equally in each group. For example, Ginkgo biloba with an additional intervention versus placebo with an identical intervention. Where an additional intervention was used equally in both groups, we analysed this as a separate comparison. </p> </section> <section id="CD013514-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We analysed the following outcomes in the review, but did not use them as a basis for including or excluding studies. </p> <section id="CD013514-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013514-list-0006"> <li> <p>Tinnitus symptom severity (such as the impact of tinnitus on quality of life, activities of daily living and sleep), as measured by the global score on a multi‐item tinnitus questionnaire (<a href="#CD013514-tbl-0003">Table 1</a>). These include: </p> <ul id="CD013514-list-0007"> <li> <p>Tinnitus Questionnaire (<a href="./references#CD013514-bbs2-0074" title="HallamRS . Manual of the Tinnitus Questionnaire (TQ). London: The Psychological Corporation, Brace &amp; Co, 1996.">Hallam 1996</a>; <a href="./references#CD013514-bbs2-0082" title="HillerW , GoebelG . A psychometric study of complaints in chronic tinnitus. Journal of Psychosomatic Research1992;36(4):337-48.">Hiller 1992</a>); </p> </li> <li> <p>Tinnitus Functional Index (<a href="./references#CD013514-bbs2-0107" title="MeikleMB , HenryJA , GriestSE , StewartBJ , AbramsHB , McArdleR , et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear and Hearing2012;33:153-76.">Meikle 2012</a>); </p> </li> <li> <p>Tinnitus Handicap Inventory (<a href="./references#CD013514-bbs2-0116" title="NewmanCW , JacobsonGP , SpitzerJB . Development of the tinnitus handicap inventory. Archives of Otolaryngology--Head and Neck Surgery1996;122:143-8.">Newman 1996</a>); </p> </li> <li> <p>Tinnitus Handicap Questionnaire (<a href="./references#CD013514-bbs2-0097" title="KukFK , TylerRS , RussellD , JordanH . The psychometric properties of a tinnitus handicap questionnaire. Ear and Hearing1990;11:434-45.">Kuk 1990</a>); </p> </li> <li> <p>Tinnitus Reaction Questionnaire (<a href="./references#CD013514-bbs2-0155" title="WilsonPH , HenryJ , BowenM , HaralambousG . Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. Journal of Speech and Hearing Research1991;34:197-201.">Wilson 1991</a>); </p> </li> <li> <p>Tinnitus Severity Scale (<a href="./references#CD013514-bbs2-0144" title="SweetowRW , LevyMC . Tinnitus severity scaling for diagnostic/therapeutic usage. Hearing Instruments1990;41:20-1.">Sweetow 1990</a>). </p> </li> </ul> </li> <li> <p>Serious adverse effects: bleeding, seizures.</p> </li> </ul> </p> <div class="table" id="CD013514-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of questionnaires measuring tinnitus symptom severity</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement instrument (author, year)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of items and subscales</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Internal consistency (Cronbach’s alpha for global<br/>score)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Functional Index (<a href="./references#CD013514-bbs2-0107" title="MeikleMB , HenryJA , GriestSE , StewartBJ , AbramsHB , McArdleR , et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear and Hearing2012;33:153-76.">Meikle 2012</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 items, 8 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.97</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Handicap Inventory (<a href="./references#CD013514-bbs2-0116" title="NewmanCW , JacobsonGP , SpitzerJB . Development of the tinnitus handicap inventory. Archives of Otolaryngology--Head and Neck Surgery1996;122:143-8.">Newman 1996</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 items, 3 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.93</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Handicap Questionnaire (<a href="./references#CD013514-bbs2-0097" title="KukFK , TylerRS , RussellD , JordanH . The psychometric properties of a tinnitus handicap questionnaire. Ear and Hearing1990;11:434-45.">Kuk 1990</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 items, 3 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.94</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Questionnaire (<a href="./references#CD013514-bbs2-0074" title="HallamRS . Manual of the Tinnitus Questionnaire (TQ). London: The Psychological Corporation, Brace &amp; Co, 1996.">Hallam 1996</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 items, 5 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.94</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Reaction Questionnaire (<a href="./references#CD013514-bbs2-0155" title="WilsonPH , HenryJ , BowenM , HaralambousG . Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. Journal of Speech and Hearing Research1991;34:197-201.">Wilson 1991</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 items, 4 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.96</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Severity Scale (<a href="./references#CD013514-bbs2-0144" title="SweetowRW , LevyMC . Tinnitus severity scaling for diagnostic/therapeutic usage. Hearing Instruments1990;41:20-1.">Sweetow 1990</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 items</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD013514-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013514-list-0008"> <li> <p>Tinnitus loudness (a change in subjective perception) measured using either patient‐reported instruments (including visual analogue scales or numerical rating scales) or performance‐based procedures (including tinnitus loudness matching or minimum masking level). </p> </li> <li> <p>Tinnitus intrusiveness measured using a self‐report multi‐item questionnaire or validated subscale (<a href="./references#CD013514-bbs2-0073" title="HallDA , SmithH , HibbertA , ColleyV , HaiderHF , HorobinA , et al, Core Outcome Measures in Tinnitus (COMiT) initiative. The COMiT'ID Study: Developing core outcome domains sets for clinical trials of sound-, psychology-, and pharmacology-based interventions for chronic subjective tinnitus in adults. Trends in Hearing2018;22:2331216518814384.">Hall 2018a</a>). </p> </li> <li> <p>Generalised depression as measured by validated questionnaires, such as the Beck Depression Inventory II (<a href="./references#CD013514-bbs2-0036" title="BeckAT , SteerRA , BrownGK . Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.">Beck 1996</a>), the depression scale of the Hospital Anxiety and Depression Scale (HADS; <a href="./references#CD013514-bbs2-0161" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica1983;67:361-70.">Zigmond 1983</a>), and the Hamilton Rating Scale for Depression (<a href="./references#CD013514-bbs2-0075" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery &amp; Psychiatry1960;23(1):56-62.">Hamilton 1960</a>). </p> </li> <li> <p>Generalised anxiety as measured by a validated scale, for example the anxiety scale of the HADS or Beck Anxiety Inventory (<a href="./references#CD013514-bbs2-0035" title="BeckAT , EpsteinN , BrownG , SteerRA . An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology1988;56(6):893-7.">Beck 1988</a>) or the Anxiety Sensitivity Index (<a href="./references#CD013514-bbs2-0128" title="ReissS , PetersonRA , GurskyDM , McNallyRJ . Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behaviour Research and Therapy1986;24(1):1-8.">Reiss 1986</a>). </p> </li> <li> <p>Health‐related quality of life as measured by a validated scale, for example the Short‐Form 36 (<a href="./references#CD013514-bbs2-0078" title="HaysRD , SherbourneCD , MazelRM . The RAND 36-Item Health Survey 1.0. Health Economics1993;2(3):217-27.">Hays 1993</a>), WHOQoLBREF (<a href="./references#CD013514-bbs2-0140" title="SkevingtonSM , LotfyM , O'ConnellKA . The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research2004;13(2):299-310.">Skevington 2004</a>), and other WHOQoL versions, and the Health Utilities Index (<a href="./references#CD013514-bbs2-0067" title="FurlongWJ , FeenyDH , TorranceGW , BarrRD . The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies. Annals of Medicine2001;33:375-84.">Furlong 2001</a>). </p> </li> <li> <p>Other adverse effects: gastrointestinal upset, headache, allergic reaction.</p> </li> </ul> </p> <p>We assessed outcomes as short‐term (less than three months) and long‐term (three to six months). We also considered whether these outcomes are sustained beyond six months. </p> </section> </section> </section> <section id="CD013514-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <p>The Cochrane ENT Information Specialist conducted systematic searches for randomised controlled trials and controlled clinical trials. There were no language, publication year or publication status restrictions. The date of the search was 7 June 2022. </p> <section id="CD013514-sec-0026"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist searched:</p> <p> <ul id="CD013514-list-0009"> <li> <p>the Cochrane ENT Register (searched via the Cochrane Register of Studies 7 June 2022);</p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL 2022, Issue 6) (searched via the Cochrane Register of Studies); </p> </li> <li> <p>Ovid MEDLINE(R) Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) (1946 to 7 June 2022); </p> </li> <li> <p>Ovid EMBASE (1974 to 7 June 2022);</p> </li> <li> <p>Ovid AMED (1985 to 7 June 2022);</p> </li> <li> <p>Web of Science, Web of Science (1945 to 7 June 2022);</p> </li> <li> <p>EBSCO CINAHL (1982 to 7 June 2022);</p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database), <a href="http://lilacs.bvsalud.org" target="_blank">lilacs.bvsalud.org</a> (searched 7 June 2022); </p> </li> <li> <p>CNKI, <a href="http://www.cnki.com.cn" target="_blank">www.cnki.com.cn</a> (searched via Google Scholar 1999 to 7 June 2022); </p> </li> <li> <p>ClinicalTrials.gov, (searched via <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> to 7 June 2022); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (search via <a href="https://trialsearch.who.int" target="_blank">https://trialsearch.who.int</a> 7 June 2022). </p> </li> </ul> </p> <p>The Information Specialist modelled subject strategies for databases on the search strategy designed for CENTRAL. Search strategies for major databases including CENTRAL are provided in <a href="./appendices#CD013514-sec-0103">Appendix 1</a>. </p> </section> <section id="CD013514-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We scanned the reference lists of identified publications for additional trials and contacted trial authors where necessary. In addition, the Information Specialist searched Ovid MEDLINE to retrieve existing systematic reviews relevant to this systematic review, so that we could scan their reference lists for additional trials. The Information Specialist also ran non‐systematic searches of Google Scholar to retrieve grey literature and other sources of potential trials. </p> <p>We did not perform a separate search for adverse effects. We considered adverse effects described in the included studies only. </p> </section> </section> <section id="CD013514-sec-0028"> <h3 class="title" id="CD013514-sec-0028">Data collection and analysis</h3> <section id="CD013514-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two authors (MS, MH, AER and DJH) independently reviewed all records retrieved to determine their eligibility for inclusion in the review. Two authors (MS, MH, AER and DJH) reviewed the full‐text articles of the retrieved studies and independently applied the inclusion criteria. Any disagreements were discussed, involving a third author if necessary until a consensus was reached. </p> </section> <section id="CD013514-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>MS, MH, AER and DJH independently extracted data using a purposefully designed data extraction form. We piloted the data extraction form on a subset of articles and revised it as indicated before formal data extraction began. Where necessary or where insufficient data were provided for the study, we contacted study authors for further information. </p> <p>Information extracted included: study design, setting, methods or randomisation and blinding, power, inclusion and exclusion criteria, type of intervention and control, treatment duration, treatment fidelity, type and duration of follow‐up, and outcome measures and statistical tests.  </p> <p>Data extracted included: baseline characteristics of participants (age, sex, duration of tinnitus, tinnitus symptom severity, tinnitus loudness and pitch estimates, details of co‐morbid hearing loss, anxiety or depression) and details of any attrition or exclusion. </p> <p>Outcome data included: group mean and standard deviation at pre‐ and post‐intervention and follow‐up, and results of any statistical tests of between‐group comparisons.  </p> <p>Where not reported or provided by the authors we estimated standard deviations in RevMan 5.3 (<a href="./references#CD013514-bbs2-0129" title="Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>) using the available data, such as standard errors, confidence intervals, P values and t values. Where data were only available in graph form, we made and agreed numeric estimates.  </p> <p>After independent data extraction by MS, MH, AER and DJH, authors reviewed the extracted data for disagreements, and revisited and discussed the relevant studies as required to reach a final consensus.  </p> </section> <section id="CD013514-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>MS, MH, AER and DJH independently assessed risk of bias of the included studies, with the following taken into consideration, as guided by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013514-bbs2-0077" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Handbook 2019</a>): </p> <p> <ul id="CD013514-list-0010"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other sources of bias.</p> </li> </ul> </p> <p>We used the Cochrane risk of bias tool in RevMan 5.3 (<a href="./references#CD013514-bbs2-0129" title="Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>), which involves describing each of these domains as reported in the trial and then assigning a judgement about the adequacy of each entry: 'low', 'high' or 'unclear' risk of bias. We resolved differences of opinion by discussion.  </p> </section> <section id="CD013514-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risk ratios (RR) with 95% confidence intervals (CIs). We summarised continuous outcomes as mean differences (MD) with 95% CI, provided that the selected studies used the same scale of measurement. We had planned to use standardised mean differences (SMD) when different scales of measurement had been used to measure the same outcome but the studies all used the same scale. </p> </section> <section id="CD013514-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>For parallel‐group RCTs the unit of analysis was the group mean. We planned to use alternative analyses for cluster‐randomised trials but none were identified. For studies with more than two intervention groups, we planned to either combine groups to create a single pair‐wise comparison or, if this was not appropriate, select the most relevant pair of interventions for comparison. We selected the most relevant pair of interventions for comparison for studies with more than two arms, in line with the comparison of interest for this review. </p> </section> <section id="CD013514-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We planned that where necessary and where sufficient data from the study were not provided, we would contact the authors of the study requesting further details about missing data and reasons for the incompleteness of the data. We were alert to potential mislabelling or non‐identification of standard errors and standard deviations. Our method for imputation would have been according to chapter Chapter 6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013514-bbs2-0077" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Handbook 2019</a>). Other missing data would not have been imputed. The studies identified did not have missing data so we performed complete case analyses and no sensitivity analysis was used. </p> </section> <section id="CD013514-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We determined whether the selected studies suffered from clinical, statistical and methodological heterogeneity. We  quantified statistical heterogeneity using the I<sup>2</sup> statistic and the Chi<sup>2</sup> test. With respect to the I<sup>2</sup> statistic, an approximate guide to interpretation is provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013514-bbs2-0077" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Handbook 2019</a>). If the I<sup>2</sup> value was 50% or higher, we considered the data to suffer from substantial or considerable heterogeneity. For the Chi<sup>2</sup> test, we used the indicator that where the Chi<sup>2</sup> is greater than the degrees of freedom (where the degrees of freedom are the number of studies K minus 1), then heterogeneity is likely to be present. We considered heterogeneity to be statistically significant if the P value was less than 0.10. Subsequently, in the absence of heterogeneity (I<sup>2</sup> = 0%, P = 0.41) we performed the meta‐analysis using a fixed‐effect model.  </p> </section> <section id="CD013514-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>We searched for and requested study protocols for the included studies and, where available, we evaluated whether there was evidence of selective reporting. We planned to assess publication bias using a funnel plot and Egger's test if a meta‐analysis contained at least 10 studies. Unfortunately, none of the meta‐analyses contained more than two studies. </p> </section> <section id="CD013514-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We planned to perform meta‐analyses using RevMan 5.3 if more than one study was identified for a given outcome (<a href="./references#CD013514-bbs2-0129" title="Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). Two studies were identified for our main outcome of tinnitus symptom severity and four for other adverse effects for the comparison of Ginkgo biloba versus placebo For other comparisons there was not data from more than one study so it was not possible to calculate a pooled estimate. </p> </section> <section id="CD013514-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out subgroup analyses to explore the potential effect modifiers of hearing loss, baseline tinnitus symptom severity and baseline anxiety or depression. However, insufficient data were available. </p> </section> <section id="CD013514-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct a sensitivity analysis by excluding those studies with a high risk of bias, thereby checking the robustness of the conclusion from the studies included in the meta‐analysis. However, only one to four studies were included in the meta‐analyses, all with similar, non‐significant estimates of effect. Moreover, all of the included studies carried a high or unclear risk of bias. </p> </section> <section id="CD013514-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>Two authors (MS and JX) used the GRADE approach to rate the overall certainty of evidence using GRADEpro GDT (<a href="https://gradepro.org/" target="_blank">https://gradepro.org/</a>). The certainty of evidence reflects the extent to which we are confident that an estimate of effect is correct and we applied this in the interpretation of results. There are four possible ratings: high, moderate, low and very low. A rating of high certainty of evidence implies that we are confident in our estimate of effect and that further research is very unlikely to change our confidence in the estimate of effect. A rating of very low certainty implies that any estimate of effect obtained is very uncertain. </p> <p>The GRADE approach rates evidence from RCTs that do not have serious limitations as high certainty. However, several factors can lead to the downgrading of the evidence to moderate, low or very low. The degree of downgrading is determined by the seriousness of these factors: </p> <p> <ul id="CD013514-list-0011"> <li> <p>study limitations (risk of bias);</p> </li> <li> <p>inconsistency;</p> </li> <li> <p>indirectness of evidence;</p> </li> <li> <p>imprecision; and</p> </li> <li> <p>publication bias.</p> </li> </ul> </p> <p>We planned to include a summary of findings table, constructed according to the recommendations described in Chapter 14 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013514-bbs2-0077" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Handbook 2019</a>), for the following comparison: </p> <p> <ul id="CD013514-list-0012"> <li> <p>Ginkgo biloba versus placebo.</p> </li> </ul> </p> <p>In addition we included a summary of findings table for the comparison:</p> <p> <ul id="CD013514-list-0013"> <li> <p>Gingko biloba with concurrent intervention versus concurrent intervention only.</p> </li> </ul> </p> <p>We included the following outcomes in the summary of findings tables:</p> <p> <ul id="CD013514-list-0014"> <li> <p>tinnitus symptom severity;</p> </li> <li> <p>serious adverse effects (bleeding disorders, seizures);</p> </li> <li> <p>tinnitus loudness;</p> </li> <li> <p>health‐related quality of life;</p> </li> <li> <p>other adverse effects (gastrointestinal upset, headache, allergic reaction).</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013514-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013514-sec-0041"></div> <section id="CD013514-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD013514-sec-0043"> <h4 class="title">Results of the search</h4> <p>Our electronic database search on 7 June 2022 identified 1036 records, of which 492 remained after removing duplicates. We discarded 455 records based on title and/or abstract. We retrieved 37 articles for full‐text screening. We excluded 17 studies because they had the wrong study design (n = 11), had the wrong intervention or comparator (n = 4), had the wrong patient population (n = 1) or were a trial that was terminated before obtaining evaluable data (n = 1) (see <a href="./references#CD013514-sec-0114" title="">Characteristics of excluded studies</a>). Two records are awaiting further classification as full texts could not be obtained (<a href="./references#CD013514-sec-0115" title="">Characteristics of studies awaiting classification</a>). Five records supplemented the methodological information that was extracted for three included studies. We identified one ongoing study (<a href="./references#CD013514-sec-0116" title="">Characteristics of ongoing studies</a>). </p> <p>In total, 12 completed studies met our inclusion criteria (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). Five of these studies reported quantitative data that we included in quantitative synthesis (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). </p> <p>We identified no additional records from other sources. A flowchart of study retrieval and selection is provided in <a href="#CD013514-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013514-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD013514-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD013514-sec-0044"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD013514-sec-0113" title="">Characteristics of included studies</a>. </p> <p>We included 12 published studies (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>).  </p> <section id="CD013514-sec-0045"> <h5 class="title">Design</h5> <p>All included studies were parallel‐group RCTs. Four of the included studies had more than two treatment arms. <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a> was a three‐arm trial comparing Ginkgo biloba, betahistine and placebo. <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> was a four‐arm trial comparing Ginkgo biloba to placebo and caroverine to placebo. <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> was a three‐arm trial comparing Ginkgo biloba, hearing aids and Ginkgo biloba with hearing aids. <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> was a four‐arm trial comparing Gingko biloba, α‐lipoic acid plus vitamin C, papaverine hydrochloride plus vitamin E and placebo. </p> </section> <section id="CD013514-sec-0046"> <h5 class="title">Sample sizes</h5> <p>The total sample size for all included studies was 1915 (range 22 to 978 participants).</p> </section> <section id="CD013514-sec-0047"> <h5 class="title">Setting</h5> <p>Seven studies were set in ENT departments in Brazil, France, Germany, India, Iran, Turkey and the UK (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), one in an audiology centre in Brazil (<a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>), one in a neurology practice in Germany (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>), one in psychiatric or neurological hospitals in Ukraine (<a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>), and one was conducted completely by email and telephone (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>). One study did not provide setting details (<a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>). </p> </section> <section id="CD013514-sec-0048"> <h5 class="title">Participants</h5> <p>Eight studies included participants with tinnitus as a main complaint. Two studies included participants with neurological conditions who also had tinnitus; in <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> all participants had either Alzheimer's disease or vascular dementia and in <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> all patients had "mild cerebral insufficiency of vascular origin". The participant groups in these two studies may not fully represent the tinnitus population (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>). <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> included participants with sensorineural hearing loss who also complained of tinnitus.  </p> <p>Eleven studies recruited adult participants (18 years or over). In one study the age range was 14 to 70 years (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>). Three studies recruited older participants: <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> recruited participants over 55 years of age, <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> 50 years or older and <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> 60 years and over. <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> had an upper age cut‐off for participants of 60 years and <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a> of 70 years. The mean age of participants in the included studies ranged from 38.8 to 66.6 years. Mean age was not reported in two studies (<a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>). </p> <p>Three studies did not report the gender of the participants (<a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>), and three did not report gender separately for the arms of interest, only for all participants in all study arms (<a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). In the remaining studies 56% of participants were men and 44% of participants were women. Men accounted for between 28% and 69% of participants, depending on the study. One study had a markedly larger proportion of women than men (<a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; 72%) and two studies had a markedly larger proportion of men than women (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; 69% and 67% respectively).  </p> <p>Baseline hearing level was rarely reported in the included studies. Only one study reported baseline hearing thresholds for participants (<a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>), with averaged air‐conduction thresholds at 0.5 kHz, 1 kHz, 2 kHz and 4 kHz for both ears of 26.8 dB in the intervention group and 35.2 dB in the placebo group. Participants in <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a> had various degrees of uni‐ or bilateral sensorineural hearing loss varying from mild to profound. In <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>, all participants had normal hearing at three neighbouring frequencies in the audiogram. <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> performed audiometry (0 kHz to 16,000 Hz) for all participants and had an inclusion criterion of "high frequency loss and sensorineural hearing loss is consistent with the diagnosis of cochlear synaptic tinnitus". Participants in <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> had a variable degree of sensorineural hearing loss confirmed by previous audiometric testing. <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a> recruited participants with normal hearing. Five studies did not report the baseline hearing level (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>).  </p> <p>Individual tinnitus duration ranged from four months to over 10 years. <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a> recruited participants with recent tinnitus, i.e. tinnitus that had appeared within less than one year and <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> with a complaint of tinnitus for at least three months. <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a> excluded patients with a tinnitus duration of less than 12 months. Tinnitus duration was not reported in <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>, <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>, <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>, <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> or <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>.  </p> <p>The majority of included studies did not specify inclusion criteria based on tinnitus symptom severity, presence of tinnitus being sufficient. <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> recruited participants with "clinical complaints of tinnitus", <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> with "complaint of tinnitus" and <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a> with "tinnitus as only or main presenting complaint". Five studies reported baseline tinnitus symptom severity. In <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>, the average tinnitus severity measure on the 1 to 4 scale (mild to severe) was 2.46 (standard deviation (SD) 0.9) in the intervention group and 2.47 (SD 0.6) in the control group. In <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, baseline tinnitus symptom severity in the whole study sample of participants with dementia measured on the 11‐point box scale (from 0 indicating absence to 10 indicating extreme severity of the symptom) was 2.1 (SD 2.3) in the Ginkgo biloba group and 2.1 (SD 2.2) in the placebo group. From 400 participants enrolled in the study 204 had tinnitus (101 in the Ginkgo biloba group and 103 in the placebo group). Baseline symptom severity for participants with tinnitus was 4.02 in the Ginkgo biloba group and 3.90 in the placebo group. Three studies reported baseline tinnitus symptom severity measured with the THI (<a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). In <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>, baseline tinnitus symptom severity measured with the THI was 32.8 (SD 19.9; range 12 to 80) in the Ginkgo biloba group and 28.2 (SD 25.1; range 2 to 72) in the placebo group. In <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>, the baseline THI scores were 57.5 (SD 7.5) in the Ginkgo biloba plus hearing aids group and 52.5 (SD 5) in the hearing aid group. In <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>, these were 37.5 (SD 20.5) in the intervention group and 50.7 (SD 23.3) in the placebo group. Baseline tinnitus symptom severity was not reported in seven studies (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). </p> <p>Baseline anxiety and/or depression scores were not reported in any of the included studies. In <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, participants with severe depression were excluded by requiring a score below 20 on the 17‐item Hamilton Rating Scale for Depression (HAMD).  </p> </section> <section id="CD013514-sec-0049"> <h5 class="title">Interventions and comparisons</h5> <p>Eleven studies evaluated the effects of Ginkgo biloba (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), and one study the effects of Ginkgo biloba with concurrent intervention (digital Beltone hearing aids) (<a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>).  </p> <p>The daily dosage of ginkgolides varied from 80 mg daily to 240 mg daily. Daily dosage was not reported in <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>. Duration of treatment varied from two weeks to six months.  </p> <p>The comparator in nine studies was a placebo not otherwise specified (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). In <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>, starch capsules were used as a placebo. In <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>, the comparator was the digital Beltone hearing aid.  </p> </section> <section id="CD013514-sec-0050"> <h5 class="title">Outcomes</h5> <p>Seven included studies used one of the pre‐specified outcome measures (<a href="#CD013514-sec-0022">Types of outcome measures</a>) (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). </p> <section id="CD013514-sec-0051"> <h6 class="title">Primary outcomes</h6> <p>Three studies reported changes in tinnitus symptom severity before and after treatment, as measured by the THI (<a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Four studies assessed the frequency of serious adverse events (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Outcomes were measured at three months (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>), and six months (<a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>).  </p> </section> <section id="CD013514-sec-0052"> <h6 class="title">Secondary outcomes</h6> <p>Three studies assessed tinnitus loudness before and after treatment (<a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a> assessed tinnitus loudness measured with loudness matching and minimum masking levels, however it did not provide before and after data for those measures. <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a> assessed loudness measured with audiometric loudness matching. <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> assessed loudness using a visual analogue scale (VAS) (range 0 to 10). One study reported change in quality of life before and after treatment, as measured by the Glasgow Health Status Inventory (GHSI) (<a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Four studies assessed other adverse effects (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>).  </p> <p>Outcomes were measured at three months (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>).   </p> <p>None of the studies reported changes in depressive symptoms or depression, anxiety symptoms or generalised anxiety. None of the studies included measures of tinnitus intrusiveness. </p> </section> <section id="CD013514-sec-0053"> <h6 class="title">Other outcomes</h6> <p><a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013093.pub2/references#CD013093-bbs2-0001" target="_blank">Cekkayan 1996</a> reported change in tinnitus symptom severity using a single‐item five‐point Likert scale: 0 = the tinnitus disappeared completely; 1 = great relief, but the complaint was still ongoing; 2 = relieved by 50%; 3 = relief was very small; 4 = no changes were noticed. <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a> reported change in loudness measured with a categorical rating scale (‐6 to 6) and change in troublesome nature of tinnitus measured with a categorical rating scale (‐4 to 4). <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> reported change in the severity of tinnitus assessed on a four‐point rating scale. <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a> reported change in tinnitus severity on a scale from 1 to 7 (1 to 2 = deterioration; 3 = no change; 4 = slight improvement; 5 = improvement; 6 = major improvement; 7 = discontinued due to intolerance). <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> reported change in tinnitus severity, using an 11‐point box scale, 0 representing absence and 10 indicating extreme severity of a symptom. <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a> reported change in tinnitus severity measured with an undefined questionnaire. Outcomes were collected at three months.  </p> </section> </section> </section> <section id="CD013514-sec-0054"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies after reviewing the full‐text paper. We excluded 11 studies because they were not RCTs (<a href="./references#CD013514-bbs2-0013" title="AbascalK , YarnellE . Herbal formulas for alleviating symptoms of tinnitus. Alternative and Complementary Therapies2012;18(2):74-7. ">Abascal 2012</a>; <a href="./references#CD013514-bbs2-0014" title="AhsanSF . Alternative medical management of tinnitus. Brain Injury Professional2017;13(1):30-3. ">Ahsan 2017</a>; <a href="./references#CD013514-bbs2-0017" title="ColesR . Trial of an extract of Ginkgo biloba (EGB) for tinnitus and hearing loss. Clinical Otolaryngology1988;13:501-4. ">Coles 1988</a>; <a href="./references#CD013514-bbs2-0018" title="DauJ . Rationale Phytotherapie: tinnitus zahlt zu den Indikationen von Ginkgo biloba. Natura Med 2000;15(12):29-31. ">Dau 2000</a>; <a href="./references#CD013514-bbs2-0019" title="FeinbergAW . Are there any studies showing whether ginkgo biloba is effective for tinnitus (ringing in the ears)?Health News (Waltham, Mass.) 2003;9(1):12. ">Feinberg 2003</a>; <a href="./references#CD013514-bbs2-0020" title="HajnaA , SejnaI . Ginkgo biloba in the treatment of tinnitus, vertigo and hypacusis. Prakticky Lekar1999;79(10):588-9. ">Hajna 1999</a>; <a href="./references#CD013514-bbs2-0021" title="HolgersKM , AxelssonA , PringleI . Ginkgo biloba extract for the treatment of tinnitus. Audiology1994;33:85-92. ">Holgers 1994</a>; <a href="./references#CD013514-bbs2-0024" title="NovotnyM , DitmarovaJ , HahnA , OšťádalováI . Tinnitus therapy with Tebokan (R) and hyperbaric oxygenation. In: OšťádalováI , editors(s). Equilibrium Research, Clinical Equilibriometry and Modern Treatment. 1st edition. Amsterdam, Lausanne, New York, Oxford: Elsevier, 1999:635-7. ">Novotny 2000</a>; <a href="./references#CD013514-bbs2-0026" title="SandnerF . With Ginkgo biloba dry leaf extract against the tinnitus (ear) orchestra in the head. Journal fur Pharmakologie und Therapie2017;26(2):54-5. ">Sadner 2017</a>; <a href="./references#CD013514-bbs2-0027" title="SchneiderD , SchneiderL , ShulmanA , ClaussenCF , JustE , KoltchevC , et al. Gingko biloba (Rokan) therapy in tinnitus patients and measurable interactions between tinnitus and vestibular disturbances. International Tinnitus Journal2000;6(1):56-62. ">Schneider 2000</a>; <a href="./references#CD013514-bbs2-0028" title="vonWedelH , CaleroL , WalgerM , HoenenS , RutwaltD . Soft-laser/ginkgo therapy in chronic tinnitus. Advances in Otorhinolaryngology1995;49:105-8. ">von Wedel 1995</a>). We excluded four studies because of the intervention or control they used (<a href="./references#CD013514-bbs2-0016" title="ClaussenCF , ClaussenE , BockingHH , PatilNP . Extractum Ginkgo biloba in the combined treatment of vertigo, nausea and tinnitus. In: ClaussenCF , KirtaneMV , SchlitterK , editors(s). Vertigo, Nausea, Tinnitus and Hypoacusia in Metabolic Disorders. Elsevier Science Publishers B.V. (Biomedical Division), 1988:583-9. ">Claussen 1988</a>; <a href="./references#CD013514-bbs2-0023" title="KieferD . Gingko benefits for tinnitus?Integrative Medicine Alert2019;22(10):1-9. ">Kiefer 2019</a>; <a href="./references#CD013514-bbs2-0025" title="PlathP , OlivierJ . Results of combined low-power laser therapy and extracts of ginkgo biloba in cases of sensorineural hearing loss and tinnitus. Advances in Otorhinolaryngology1995;49:101-4. ">Plath 1995</a>; <a href="./references#CD013514-bbs2-0029" title="WalgerM , vonWedelH , CaleroL , HoenenS , RutwaltD . Ergegnisse einer studie zur effektivitat einer kombinierten low-power-laser und gingko-therapie auf den chronischen tinnitus. HNO - Informationen1993;4:35-6. ">Walger 1993</a>), and one study because of the patient population (<a href="./references#CD013514-bbs2-0015" title="BruchertE , HeinrichSE , Ruf-KohlerP . Effectiveness of LI 1370 in patients with cognitive insufficiency. Munchener Medizinische Wochenschrift 1991;133(Suppl 1):S9-14. ">Bruchert 1991</a>). See <a href="./references#CD013514-sec-0114" title="">Characteristics of excluded studies</a> for details. </p> <p>Two studies are awaiting classification as full texts could not be obtained (<a href="./references#CD013514-bbs2-0030" title="FandriantikaDR . Penanganan Tinnitus Dengan Titik Akupunktur Yifeng (SJ17), Tinggong (SI19), Taixi (KI3) Serta Pemberian Herba Ginkgo Biloba [Thesis]. Universitas Airlangga, 2017. [REPOSITORY WEBSITE: http://repository.unair.ac.id/id/eprint/65655]">Fandriantika 2017</a>; <a href="./references#CD013514-bbs2-0031" title="RogowskiM , BartnikG , FabijanskaA . Randomized double-blind drug/retraining vs placebo/retraining study of the treatment of tinnitus with Ginkgo biloba extract (EGb 761). European Archives of Oto-rhino-laryngology 2001;258(8):4222001. ">Rogowski 2001</a>). </p> <p>We identified one ongoing study comparing oral administration of Ginkgo biloba extract tablets with medication combined with music in people with tinnitus (<a href="./references#CD013514-sec-0116" title="">Characteristics of ongoing studies</a>).  </p> </section> </section> <section id="CD013514-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed risk of bias based on the information provided in the published reports. See <a href="#CD013514-fig-0002">Figure 2</a> and <a href="#CD013514-fig-0003">Figure 3</a> for a graph and summary of risk of bias across studies. </p> <div class="figure" id="CD013514-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013514-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013514-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013514-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013514-sec-0056"> <h4 class="title">Allocation</h4> <section id="CD013514-sec-0057"> <h5 class="title">Random sequence generation</h5> <p>We considered the risk of selection bias due to inadequate sequence generation to be high in two studies (<a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), unclear in three studies (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>), and low in seven studies (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). In <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>, an author confirmed the study was randomised but disclosed that there was a potential bias in the selection of participants. In <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>, Ginkgo and placebo tablets were placed in an equal number of paper bags and the doctor randomly administered the content of the bags to the patient. Four studies reported that participants had been randomised to the treatment arms, but did not provide further information on the method of sequence generation (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>). <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a> paired participants according to pre‐defined criteria and each pair was then allocated two numbers from a randomly arranged code; one number corresponded to placebo treatment and one to active treatment. In <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>, intervention or placebo were randomly assigned by a computer program to participant enrolment numbers. In <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, centre‐stratified randomisation (drug–placebo ratio 1:1) in blocks of four was performed by the sponsor's biometrics unit using a validated computer program that linked ascending drug numbers to active drug or placebo, respectively. <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> used computer‐generated block randomisation to randomise participants into four groups. <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> used <a href="http://www.randomization.com" target="_blank">http://www.randomization.com</a> for distribution and randomisation of participants. In <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>, the random allocation process consisted of generating a random sequence using an Excel file and used the random allocation rule, which chooses at random one of the possible balanced assignments of the given number of participants per treatment. In <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>, randomisation was carried out by an independent third party using a card from bag system. </p> </section> <section id="CD013514-sec-0058"> <h5 class="title">Allocation concealment</h5> <p>We judged three studies to have low risk of bias for allocation concealment (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). In <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, placebo tablets of identical size and colour were dispensed in coded bottles, and treatment allocation was masked. The allocation procedure ensured that all matched participants received active or placebo tablets without the code being identified. In <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, the randomisation list was sealed and stored safely at the sponsor's biometrics unit, and block length was not disclosed to investigators. In <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>, randomisation was carried out by an independent third party using a card from bag system. For the remaining nine studies, risk of bias due to allocation concealment was unclear as the information was not reported (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). </p> </section> </section> <section id="CD013514-sec-0059"> <h4 class="title">Blinding</h4> <section id="CD013514-sec-0060"> <h5 class="title">Blinding of participants and personnel </h5> <p>We judged the risk of performance bias to be low in six studies (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). In <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, placebo tablets were identical to the active tablets in shape, size, colour and packaging, and provided by the third party (Lichtwer Pharma). The allocation procedure ensured that all matched participants received active or placebo tablets without the code being identified. <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> used identical tablets for intervention and placebo; neither the patient nor the examining physician knew the assignment and the code was only opened after the data collection had been completed at the beginning of the evaluation. In <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, drug and placebo tablets were indistinguishable by appearance, packaging and labelling. <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> stated that the substances were not identified by name in the containers into which they were packed, but rather through symbols defined by a professional who did not participate in the research, as a way of blinding investigators and participants. In <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>, all tablets were provided by third party (Lambert’s Health Care, Tunbridge Wells, UK). <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a> stated that the doctor and patients were unaware of the type of medication, with only the second co‐researcher in charge of numbering and packaging the bags being aware. We judged the risk of performance bias to be unclear in five of the included studies, as the information regarding blinding was not provided in the records (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>), and high in one study as due to the nature of the intervention (hearing aids) participants were not blinded (Radnuz 2019). However, the examiners responsible for applying the questionnaires during the study were blinded to the intervention (<a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). </p> </section> <section id="CD013514-sec-0061"> <h5 class="title">Blinding of outcome assessment </h5> <p>The risk of detection bias was low in three studies (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). In <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, data entry and initial analyses were carried out by a researcher blinded to the participant's allocation. In <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>, neither the patient nor the examining physician knew the assignment; the code was only opened after the data collection had been completed at the beginning of the evaluation. In <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>, the examiners responsible for applying the questionnaires during the study were blinded to the intervention. In addition, an employee outside the research team inserted data into the computer in separate data sheets so that the researchers could analyse data without having access to information about the allocation. The risk of detection bias was unclear in the remaining nine studies as the information was not provided (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>).  </p> </section> </section> <section id="CD013514-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>We judged four studies to have high risk of bias due to incomplete outcome data (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>).  <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a> reported data on changes in tinnitus symptom severity only for 8 out of 15 participants, without explaining reasons for dropout; all missing data were for participants in the placebo group. For <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a> only a brief abstract was available and we were not able to obtain additional information from the authors. No information was provided on the number of participants who completed the study and completeness of outcome measures. In <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>, there were missing data for the primary outcome measure for 14 (out of 49) participants in the intervention group and 12 (out of 50) in the control group at 12 weeks; this dropout was not explained. In <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>, 15 placebo and 14 test participants who had tinnitus participated in the trial, however data for only 12 and 13 participants respectively were included in the report without reasons for dropout/exclusion given. We judged <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a> to have an unclear risk of bias. The study paired participants according to pre‐defined criteria, however only 956 out of 1121 participants were paired. The remaining 165 participants were also randomised and analysed, however analyses on unmatched data were not reported, except the statement that: "Unmatched analyses did not provide any additional information and have therefore been excluded from this paper". We judged seven studies to have low risk of bias due to incomplete outcome data as all participant data were reported or reasons for dropout were explained (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). </p> </section> <section id="CD013514-sec-0063"> <h4 class="title">Selective reporting</h4> <p>We judged seven studies to have high risk of bias due to selective reporting (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). In <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>, routine and audiological examinations were performed every 15 days, however those data were not reported. For <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a> it was not clear whether all primary outcomes were reported. In addition, no data on secondary outcomes were reported. In <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>, the data for most secondary outcome measures were not reported. For <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> there were two reports from the study, one reporting the tinnitus score in the whole study population (from 0 ‐ absence of tinnitus to 10 ‐ extreme severity) and one brief report reporting tinnitus scores only in those participants with tinnitus. No additional data were reported specifically for participants with tinnitus. <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a> specified quality of life as a primary outcome measure but no results were reported. The manuscript mentioned that "tinnitus matching" improved but this was not pre‐defined as an outcome measure. The trial registration for <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> lists hearing improvement in an audiometric test as a primary outcome, however this outcome was not described. In <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>, a questionnaire of tinnitus severity was used as an outcome measure but not described; the authors interpreted the result as no change, improvement and exacerbation but it is unclear what were the criteria for such classifications. We judged two studies to have an unclear risk of bias (<a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>). <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a> did not specify outcomes. In <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>, no values for secondary outcome measures were reported, only brief statements regarding whether those improved or not were included. <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> and <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a> reported all pre‐specified outcome measures, therefore we judged the risk of bias to be low.  </p> </section> <section id="CD013514-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p>Conflict of interest was not reported in eight studies (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), and funding was not disclosed in seven studies (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>). For nine studies there was no prospective protocol or trial registration available (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>).  </p> <p><a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a> did not report the statistical tests used, therefore it was not possible to judge whether the analysis of the results was appropriate. In <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, there was limited reporting of baseline data regarding tinnitus characteristics and severity. Participants were matched for age, sex and duration of tinnitus and stated cause of tinnitus but not severity. No data regarding 'unmatched' participant characteristics (i.e. was a specific group excluded from the analysis) were reported. In <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>, when contacted, one of the authors expressed concerns regarding the quality of the study, however no additional details were provided. <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> was a trial with patients with "mild cerebral insufficiency of vascular origin" and tinnitus was a secondary outcome measure. No study registration or protocol was available. For <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a> only an abbreviated version of the full study report was available. <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> was a study of the effects of Ginkgo biloba on Alzheimer's disease or vascular dementia and tinnitus was a secondary outcome measure. In <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>, there were no criteria for defining tinnitus improvement, no statistical analyses were described and the results did not justify the conclusions. Audiological selection criteria were complex and of uncertain significance in selecting the stated aetiological group. <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a> was a trial concentrating on hearing loss, with tinnitus as a secondary outcome. In <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>, baseline tinnitus severity was significantly higher in the control group than in the intervention group. No other sources of bias were identified for <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>. </p> </section> </section> <section id="CD013514-sec-0065"> <h3 class="title" id="CD013514-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD013514-tbl-0001"><b>Summary of findings 1</b> Ginkgo biloba compared to placebo for tinnitus</a>; <a href="./full#CD013514-tbl-0002"><b>Summary of findings 2</b> Gingko biloba with concurrent intervention versus concurrent intervention only</a> </p> <p>See: <a href="./full#CD013514-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013514-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD013514-sec-0066"> <h4 class="title">Ginkgo biloba versus placebo</h4> <section id="CD013514-sec-0067"> <h5 class="title">Primary outcomes</h5> <section id="CD013514-sec-0068"> <h6 class="title">Tinnitus symptom severity </h6> <p>Two studies measured tinnitus symptom severity using a multi‐item questionnaire (<a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Both studies used the Tinnitus Handicap Inventory (THI). Outcomes were measured at 12 weeks (<a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>) and six months (<a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>). Ginkgo biloba may have little to no effect on THI scores compared to placebo, but the evidence is very uncertain. The pooled mean difference (MD) was ‐1.35 (scale 0 to 100; 95% confidence interval (CI) ‐8.26 to 5.55; 2 studies; 85 participants) (<a href="./references#CD013514-fig-0004" title="">Analysis 1.1</a>) (GRADE: very low‐certainty).   </p> </section> <section id="CD013514-sec-0069"> <h6 class="title">Serious adverse effects</h6> <p>Four studies reported adverse effects at three months follow‐up (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Ginkgo biloba may results in little to no difference in the risk of bleeding or seizures, with no serious adverse effects reported in either the Ginkgo biloba or placebo group (4 studies; 1154 participants; low‐certainty) (<a href="./references#CD013514-fig-0005" title="">Analysis 1.2</a>).  </p> </section> </section> <section id="CD013514-sec-0070"> <h5 class="title">Secondary outcomes</h5> <section id="CD013514-sec-0071"> <h6 class="title">Tinnitus loudness</h6> <p><a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a> found that there may be little to no difference between the effect of Ginkgo biloba or placebo on tinnitus loudness measured with audiometric loudness matching at 12 weeks, but the evidence is very uncertain (MD ‐4.00 (scale ‐10 to 140 dB), 95% CI ‐13.33 to 5.33; 1 study; 73 participants) (<a href="./references#CD013514-fig-0006" title="">Analysis 1.3</a>) (GRADE: very low‐certainty).  </p> </section> <section id="CD013514-sec-0072"> <h6 class="title">Tinnitus intrusiveness</h6> <p>None of the studies included measures of tinnitus intrusiveness.</p> </section> <section id="CD013514-sec-0073"> <h6 class="title">Generalised depression</h6> <p>None of the studies included measures of generalised depression.</p> </section> <section id="CD013514-sec-0074"> <h6 class="title">Generalised anxiety</h6> <p>None of the studies included measures of generalised anxiety.</p> </section> <section id="CD013514-sec-0075"> <h6 class="title">Health‐related quality of life</h6> <p><a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a> found that there may be little to no difference in health‐related quality of life measured with the Glasgow Health Status Inventory (GHSI) at three months (MD ‐0.58 (scale 0 to 100), 95% CI ‐4.67 to 3.51; 1 study; 60 participants) (<a href="./references#CD013514-fig-0007" title="">Analysis 1.4</a>) (GRADE: low‐certainty).  </p> </section> <section id="CD013514-sec-0076"> <h6 class="title">Other adverse effects</h6> <p>Four studies reported adverse effects at three months follow‐up (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). None of the participants reported adverse effects in <a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a> and <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>. In <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>, participants reported gastrointestinal upset (14 in the intervention group and 14 in the placebo group), headache (4 and 4 respectively) and allergic skin reaction (2 and 3 respectively) and in <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a> participants reported gastrointestinal upset (2 in the intervention group and 1 in the placebo group) and headache (1 in each group). When we pooled the data we found that Ginkgo biloba may not increase the frequency of other adverse effects compared to placebo (risk ratio 0.91, 95% CI 0.52 to 1.60; 4 studies; 1175 participants) (<a href="./references#CD013514-fig-0008" title="">Analysis 1.5</a>) (GRADE: low‐certainty). </p> </section> </section> </section> <section id="CD013514-sec-0077"> <h4 class="title">Gingko biloba with concurrent intervention versus concurrent intervention only</h4> <section id="CD013514-sec-0078"> <h5 class="title">Primary outcomes</h5> <section id="CD013514-sec-0079"> <h6 class="title">Tinnitus symptom severity </h6> <p><a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> measured tinnitus symptom severity with the THI at three months. We found that when Ginkgo biloba was used alongside hearing aids, the reduction in tinnitus symptom severity (as measured by the THI) at three months was not as great as when hearing aids were used alone, but the evidence is very uncertain (MD 7.50 (scale 0 to 100), 95% CI 2.83 to 12.17; 1 study; 22 participants) (<a href="./references#CD013514-fig-0009" title="">Analysis 2.1</a>) (GRADE: very low‐certainty).  </p> </section> <section id="CD013514-sec-0080"> <h6 class="title">Serious adverse effects</h6> <p>The study did not report serious adverse effects.</p> </section> </section> <section id="CD013514-sec-0081"> <h5 class="title">Secondary outcomes</h5> <section id="CD013514-sec-0082"> <h6 class="title">Tinnitus loudness</h6> <p><a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a> measured tinnitus loudness using a visual analogue scale (VAS) at three months. We found that when Ginkgo biloba was used alongside hearing aids, the reduction in tinnitus loudness (as measured by VAS) at three months was not as great as when hearing aids were used alone, but the evidence is very uncertain (MD 1.00 (scale 0 to 10), 95% CI 0.52 to 1.48; 1 study; 22 participants) (<a href="./references#CD013514-fig-0010" title="">Analysis 2.2</a>) (GRADE: very low‐certainty).  </p> </section> <section id="CD013514-sec-0083"> <h6 class="title">Tinnitus intrusiveness</h6> <p>The study did not include measures of tinnitus intrusiveness.</p> </section> <section id="CD013514-sec-0084"> <h6 class="title">Generalised depression</h6> <p>The study did not include measures of generalised depression.</p> </section> <section id="CD013514-sec-0085"> <h6 class="title">Generalised anxiety</h6> <p>The study did not include measures of generalised anxiety.</p> </section> <section id="CD013514-sec-0086"> <h6 class="title">Health‐related quality of life</h6> <p>The study did not include measures of health‐related quality of life.</p> </section> <section id="CD013514-sec-0087"> <h6 class="title">Other adverse effects</h6> <p>The study did not report other adverse effects.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013514-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013514-sec-0088"></div> <section id="CD013514-sec-0089"> <h3 class="title" id="CD013514-sec-0089">Summary of main results</h3> <p>The objective of this review was to assess the effects of Ginkgo biloba for subjective tinnitus in adults and children. This review included 12 studies (1915 participants). Eleven studies investigated the effects of Ginkgo biloba compared to placebo (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), and one study investigated the effects of Ginkgo biloba plus hearing aids compared to hearing aids alone (<a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). Only six studies reported outcomes of interest to this review.  </p> <section id="CD013514-sec-0090"> <h4 class="title">Ginkgo biloba versus placebo</h4> <p>At three to six months, Ginkgo biloba may have little to no effect on Tinnitus Handicap Inventory (THI) scores but the evidence is very uncertain. No participants in either the Ginkgo biloba or placebo groups reported serious adverse effects (bleeding, seizures) in the included studies. One study found that there may be little to no difference between Ginkgo biloba and placebo in tinnitus loudness at 12 weeks. One study found that there may be little to no difference between Ginkgo biloba and placebo in health‐related quality of life at three months. Ginkgo biloba may not increase the frequency of other adverse effects (such as gastrointestinal upset, headache, allergic reaction) at three months compared to placebo. </p> <p>None of the studies reported the other secondary outcomes of changes in depressive symptoms or depression, anxiety symptoms or generalised anxiety, or tinnitus intrusiveness. </p> <p>There is insufficient evidence to support the superiority or inferiority of Ginkgo biloba over placebo. See <a href="./full#CD013514-tbl-0001">summary of findings Table 1</a>. </p> </section> <section id="CD013514-sec-0091"> <h4 class="title">Gingko biloba with concurrent intervention versus concurrent intervention only</h4> <p>The use of Ginkgo biloba alongside hearing aids may result in a smaller reduction in tinnitus symptom severity (measured with the THI) and tinnitus loudness (measured with a visual analogue scale) at three months compared to when hearing aids are used alone but the evidence is very uncertain. </p> <p>The study did not report tinnitus intrusiveness, or changes in depressive symptoms or depression, anxiety symptoms or generalised anxiety as measured by a validated instrument. </p> <p>The evidence is very uncertain about the effect of Ginkgo biloba on the reduction in tinnitus symptom severity when used alongside hearing aids.  </p> <p>See <a href="./full#CD013514-tbl-0002">summary of findings Table 2</a>. </p> </section> </section> <section id="CD013514-sec-0092"> <h3 class="title" id="CD013514-sec-0092">Overall completeness and applicability of evidence</h3> <p>Only six studies reported outcomes of interest to this review and contributed to the meta‐analyses (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). Nine studies included participants with subjective idiopathic tinnitus as a main complaint. Two studies included participants with neurological conditions who also had tinnitus; in <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a> all participants had either Alzheimer's disease or vascular dementia and in <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a> all patients had "mild cerebral insufficiency of vascular origin". The participant groups in these two studies may not fully represent the tinnitus population.  </p> <p>Only one study recruited participants with recent onset of tinnitus (&lt; 12 months; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>), therefore we were not able to compare the effects of Ginkgo biloba for acute (≤ 3 months) versus chronic (&gt; 3 months) tinnitus. Eleven out of 12 included studies included adult participants, with only one study recruiting patients from 14 years. Three studies recruited older participants (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>), while two studies had an upper age cut‐off of 60 or 70 years (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>). There were no studies assessing the effects of Ginkgo biloba for tinnitus in children as a standalone group. One study had a markedly larger proportion of women than men (<a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; 72%) and two studies had a markedly larger proportion of men than women (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; 69% and 67% respectively). Baseline hearing level was rarely reported in the included studies. Only one study reported baseline hearing thresholds for participants (<a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a> recruited participants with normal hearing. Most included studies did not specify inclusion criteria based on tinnitus symptom severity, presence of tinnitus being sufficient. Therefore, it was not possible to judge whether different study populations were representative of the whole tinnitus population with respect to hearing loss and tinnitus symptom severity. One study excluded participants with severe depression (<a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>).  </p> <p>Eleven studies evaluated the effects of Ginkgo biloba (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>), and one study evaluated the effects of Ginkgo biloba with digital Beltone hearing aids (<a href="./references#CD013514-bbs2-0010" title="RadunzCL , OkuyamaCE , Branco-BarreiroFCA , PereiraRMS , DinizSN . Clinical randomized trial study of hearing aids effectiveness in association with Ginkgo biloba extract (EGb 761) on tinnitus improvement. Brazilian Journal of Otorhinolaryngology2020;86(6):734-42. ">Radnuz 2019</a>). The daily dosage varied from 80 mg daily to 240 mg daily and the duration of treatment varied from two weeks to six months.  </p> <p>The comparator in nine studies was a placebo not otherwise specified (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0003" title="FucciMJ , MartinWH , FosterWP , SchweglerJW , RonisML . Effects of Ginkgo biloba extract on tinnitus: a double blind study. In: Association for Research in Otolaryngology (HRSG). 15th Midwinter Research Meeting. 1992:112 . ">Fucci 1992</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>; <a href="./references#CD013514-bbs2-0012" title="YarmoammadiME , NaseriM , Nabavi SM, Zanganeh A, Zayeri F. The efficacy of Gingko-TD on amelioration of subjective tinnitus. Bimonthly Scientific Research Journal of Shahed University2007;14(67):67-71. ">Yarmohammadi 2007</a>). In <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>, starch capsules were used as a placebo. In the analyses we pooled the different dosages and types of placebo together. In Radnuz 2019, the comparator was a digital Beltone hearing aid. </p> </section> <section id="CD013514-sec-0093"> <h3 class="title" id="CD013514-sec-0093">Quality of the evidence</h3> <p>The certainty of the evidence ranged from very low to low. We are uncertain about the estimates for change in tinnitus symptom severity, tinnitus loudness assessed with audiometric matching or visual analogue scale, quality of life and other adverse effects. The certainty of the evidence was affected by several issues, including multiple domains of high or unclear risk of bias, indirectness of evidence, imprecision and possible publication bias. Allocation concealment and blinding of participants, personnel and outcome assessments were poorly reported. Most studies were characterised by high or unclear risk of selection bias and multiple other sources of bias were identified. Only three of the included studies had a pre‐published protocol available. </p> </section> <section id="CD013514-sec-0094"> <h3 class="title" id="CD013514-sec-0094">Potential biases in the review process</h3> <p>Our searches of the electronic databases were comprehensive. We also searched the reference lists of the included studies and previous Cochrane Review (<a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>). Language was not a barrier to inclusion and we obtained translations of the articles in French, German, Turkish and Persian. All author roles were pre‐defined in the review process. Two authors selected studies for inclusion and judged risk of bias independently, with recourse to a third author for resolution of any disagreement or uncertainty. Two authors independently extracted data to minimise personal bias. We adhered to a pre‐published protocol and no post hoc decisions or changes were made (<a href="./references#CD013514-bbs2-0163" title="SeredaM , XiaJ , ScuttP , HiltonMP , El RefaieA , HoareDJ . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2019, Issue 12. Art. No: CD013514. [DOI: 10.1002/14651858.CD013514]">Sereda 2019</a>).  </p> </section> <section id="CD013514-sec-0095"> <h3 class="title" id="CD013514-sec-0095">Agreements and disagreements with other studies or reviews</h3> <p>This is a new review, superseding the previous Cochrane Review on Ginkgo biloba for tinnitus (<a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>). <a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a> included three studies, all considering patients with tinnitus as a primary complaint. All three trials included in <a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a> were also included in the current review. We also included two studies that had been excluded from <a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a> due to lack of preferred outcomes (<a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>) and differences in baseline tinnitus severity between intervention and placebo groups (<a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>), as those reasons are no longer considered sufficient for exclusion (<a href="./references#CD013514-bbs2-0077" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Handbook 2019</a>). In the current review we identified and included an additional seven studies with both participants with a primary complaint of tinnitus as well as tinnitus associated with neurological conditions. Similarly to the current review <a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a> concluded that there was no evidence that Ginkgo biloba was effective for tinnitus, with a relatively small incidence of adverse effects that was similar between the intervention and placebo groups.  </p> <p>A search for systematic reviews of the effectiveness of Ginkgo biloba for tinnitus identified three reviews (<a href="./references#CD013514-bbs2-0063" title="ErnstE , Stevinson C . Ginkgo biloba for tinnitus: a review. Clinical Otolaryngology and Allied Sciences1999;24(3):164-7.">Ernst 1999</a>; <a href="./references#CD013514-bbs2-0084" title="HiltonMP , ZimmermannEF , HuntWT . Ginkgo biloba for tinnitus. Cochrane Database of Systematic Reviews2013, Issue 3. Art. No: CD003852. [DOI: 10.1002/14651858.CD003852.pub3]">Hilton 2013</a>; <a href="./references#CD013514-bbs2-0153" title="vonBoetticherA . Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatric Disease and Treatment2011;7:441-7.">von Boetticher 2011</a>) referring to four randomised trials (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0005" title="MeyerB . A multicentre, randomized, double-blind drug versus placebo study of Ginkgo biloba extract in the treatment of tinnitus [Etude multicentrique randomisee a double insu faceau placebo du traitmement des acouphens par l'extrait de Ginkgo biloba]. Presse Medicale1986;15:1562-4. ">Meyer 1986</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>), which included 1246 patients (<a href="./references#CD013514-bbs2-0095" title="KramerF , Ortigoza Á. Ginkgo biloba for the treatment of tinnitus. Medwave2018;18(6):e7294.">Kramer 2018</a>). The authors concluded that Ginkgo biloba probably did not decrease the severity of tinnitus, did not improve quality of life and did not reduce the intensity of tinnitus. Additionally, Ginkgo biloba was not associated with adverse effects in patients with tinnitus, namely there was no difference in the type and frequency of adverse effects between the intervention and placebo groups (<a href="./references#CD013514-bbs2-0095" title="KramerF , Ortigoza Á. Ginkgo biloba for the treatment of tinnitus. Medwave2018;18(6):e7294.">Kramer 2018</a>).   </p> <p>A review looking at the effects of Ginkgo biloba on neurosensory symptoms (tinnitus and dizziness) in patients with dementia concluded that Ginkgo biloba was effective in alleviating tinnitus in those patients (<a href="./references#CD013514-bbs2-0143" title="SpiegelR , KallaR , MaireR , MuellerH , HoerrR , IhlR . Ginkgo biloba extract EGb 761® alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trials. Clinical Interventions in Aging2018;13:1121–7.">Spiegel 2018</a>). It is interesting to hypothesise why there might be a favourable response to Ginkgo biloba when tinnitus is associated with cognitive insufficiency. The aetiology of tinnitus in cognitive insufficiency is different from primary tinnitus. For example, tinnitus in cognitive insufficiency may be caused by central vascular insufficiency or a neural metabolic disorder, whereas in primary tinnitus the initiating pathology is a cochlear disorder. Changes in vascular perfusion and neuronal metabolism are well‐documented effects of Ginkgo biloba in animal and human studies. Improved cognitive functioning with Ginkgo biloba may also allow habituation to tinnitus. Habituation to repetitive presentation of a sensory stimulus or perception is the norm. There is a strong psychological component in appropriate habituation to tinnitus. If Ginkgo biloba causes a significant improvement in overall cognitive functioning then a positive effect on tinnitus may be real, but non‐specific. A Cochrane Review, however, concluded that the evidence that Ginkgo biloba has a predictable and clinically significant benefit for people with dementia or cognitive impairment is inconsistent and unreliable (<a href="./references#CD013514-bbs2-0038" title="BirksJ , Grimley Evans J . Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: CD003120. [DOI: 10.1002/14651858.CD003120.pub3]">Birks 2009</a>). In the current review we included the studies <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>, where all participants had either Alzheimer's disease or vascular dementia, and <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>, where all patients had "mild cerebral insufficiency of vascular origin". However, neither of the studies included outcomes of interest to the current review.  </p> <p>Several reviews reported side effects of Ginkgo biloba such as gastrointestinal problems, headache, nausea and vomiting, which were usually mild and reversible (<a href="./references#CD013514-bbs2-0064" title="ErnstE . The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Annals of Internal Medicine2002;136:42-53.">Ernst 2002</a>; <a href="./references#CD013514-bbs2-0106" title="MeiN , GuoX , RenZ , KobayashiD , WadaK , GuoL . Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis &amp; Ecotoxicology Reviews2017;35(1):1-28.">Mei 2017</a>; <a href="./references#CD013514-bbs2-0124" title="RajarajanG , Pavithra PriyadorshoniSP , GeethaRV . A review on the medicinal properties of Gingko biloba. Drug Invention Today2018;10(3):3420-3.">Rajarajan 2018</a>). Serious adverse effects were rare but these can include bleeding problems and seizures. The most serious adverse effects reported relate to the interactions of Ginkgo biloba with other drugs, such as anticoagulant medications, which results in the reports of haemorrhage, haematoma, apraxia, permanent neurological deficit and death (<a href="./references#CD013514-bbs2-0123" title="PosadzkiP , WatsonL , ErnstE . Herb-drug interaction: an overview of systematic reviews. British Journal of Clinical Pharmacology2012;75(3):603-18.">Posadzki 2012</a>). Only four studies in the current review reported adverse effects (<a href="./references#CD013514-bbs2-0001" title="CekkayanS , OzlüoğluL , YoloğluS , SöylemezoğluS , ErpekG . Comparison of the efficiency of betahistine hydrochloride and gingko biloba extract in tinnitus patients [Tinnituslu hastalarda betahistin ve gingko biloba ekstresinin etkinliginin karsilastirilmasi]. K.B.B. ve Baş Boyun Cerrahisi Dergisi1996;4:19-22. ">Cekkayan 1996</a>; <a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0006" title="MorgensternC , BiermannE . Long term therapy of tinnitus with Gingko biloba extract EGb 761 [Tinnitus-langzeittherapiemit Ginkgo-spezialextrakt EGb 761]. Fortschritte der Medizin1997;115(29):57-8. ">Morgenstern 1997</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). They included gastrointestinal upset, headache and allergic skin reaction. None of the studies reported any serious adverse effects, however it is worth noting that six studies excluded patients using concurrent anticoagulant medications (<a href="./references#CD013514-bbs2-0002" title="DrewS , DaviesE . Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ2001;322(7278):73. [DOI: 10.1136/bmj.322.7278.73]DrewSJ , DaviesWE . Ginkgo biloba in the treatment of tinnitus: preliminary results of a match-paired, double-blinded placebo-controlled trial involving 1115 subjects. In: Proceedings of the Sixth International Tinnitus Seminar. Cambridge, UK, 1999:261-5. ">Drew 2001</a>; <a href="./references#CD013514-bbs2-0004" title="HalamaP , BartschG , MengG . Cerebrovascular insufficiency - placebo-controlled, randomized, double blind-trial on the effect of Gingko biloba-extract [Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirkamskeit von Gingko-biloba-Extrakt]. Fortschritte der Medizin1988;106(19):54-60. ">Halama 1988</a>; <a href="./references#CD013514-bbs2-0007" title="HoerrR , NapryeyenkoO , BorzenkoI . Effects of ginkgo biloba extract EGb 761 on dizziness and tinnitus in patients with dementia. Focus on Alternative and Complementary Therapies2007;12:26-7. NapryeyenkoO , BorzenkoI , for the GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. Arzneimittel-Forschung (Drug Research)2007;57(1):4-11. NapryeyenkoO , SonnikG , TartakovskyI . Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. Neurological Sciences2009;283(1-2):224-9. ">Napryeyenko 2009</a>; <a href="./references#CD013514-bbs2-0008" title="NishadRK , JainAK , SinghM , VermaR , JainS . Randomised controlled clinical study of injection caroverine and Ginkgo biloba extract in cochlear synaptic tinnitus. Indian Journal of Otolaryngology &amp; Head &amp; Neck Surgery2019;71(Suppl 2):1523-8. ">Nishad 2019</a>; <a href="./references#CD013514-bbs2-0009" title="PolanskiJF , CruzOL . Evaluation of antioxidant treatment in presbycusis: prospective, placebo-controlled, double-blind, randomised trial. Journal of Laryngology &amp; Otology2013;127:134-41. PolanskiJF , SoaresAD , deMendonça CruzOL . Antioxidant therapy in the elderly with tinnitus. Brazilian Journal of Otorhinolaryngology2016;82(3):269-74. ">Polanski 2016</a>; <a href="./references#CD013514-bbs2-0011" title="RejaliD , SivakumarA , BalajiN . Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clinical Otolaryngology and Allied Sciences2004;29(3):226-31. ">Rejali 2004</a>). The frequency of adverse effects was relatively small and similar in the intervention and placebo groups. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013514-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD013514-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013514-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013514-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ginkgo biloba versus placebo, Outcome 1: Tinnitus symptom severity (THI) at 3 to 6 months" data-id="CD013514-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Ginkgo biloba versus placebo, Outcome 1: Tinnitus symptom severity (THI) at 3 to 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ginkgo biloba versus placebo, Outcome 2: Serious adverse effects at 3 months (yes or no)" data-id="CD013514-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Ginkgo biloba versus placebo, Outcome 2: Serious adverse effects at 3 months (yes or no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ginkgo biloba versus placebo, Outcome 3: Tinnitus loudness measured by audiometric loudness matching at 12 weeks" data-id="CD013514-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Ginkgo biloba versus placebo, Outcome 3: Tinnitus loudness measured by audiometric loudness matching at 12 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ginkgo biloba versus placebo, Outcome 4: Health‐related quality of life at 3 months" data-id="CD013514-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Ginkgo biloba versus placebo, Outcome 4: Health‐related quality of life at 3 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Ginkgo biloba versus placebo, Outcome 5: Other adverse effects at 3 months (yes or no)" data-id="CD013514-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Ginkgo biloba versus placebo, Outcome 5: Other adverse effects at 3 months (yes or no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gingko biloba with concurrent intervention versus concurrent intervention only, Outcome 1: Tinnitus symptom severity (THI) at 3 months" data-id="CD013514-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Gingko biloba with concurrent intervention versus concurrent intervention only, Outcome 1: Tinnitus symptom severity (THI) at 3 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013514-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/urn:x-wiley:14651858:media:CD013514:CD013514-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gingko biloba with concurrent intervention versus concurrent intervention only, Outcome 2: Tinnitus loudness (VAS) at 3 months (range 0 to 10)" data-id="CD013514-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_t/tCD013514-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Gingko biloba with concurrent intervention versus concurrent intervention only, Outcome 2: Tinnitus loudness (VAS) at 3 months (range 0 to 10) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/media/CDSR/CD013514/image_n/nCD013514-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013514-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ginkgo biloba compared to placebo for tinnitus</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Ginkgo biloba compared to placebo for tinnitus</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> adults with tinnitus<br/><b>Setting: </b> departments of otorhinolaryngology in Brazil, Germany and Turkey and one study conducted by telephone/email<br/><b>Intervention:</b> Ginkgo biloba<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Ginkgo biloba</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus symptom severity </p> <p> </p> <p>Assessed with: THI (range: 0 to 100)</p> <p>Follow‐up: 3 to 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus symptom severity at 3 to 6 months was 4</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.35 lower<br/>(8.26 lower to 5.55 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may have little to no effect on tinnitus severity compared to placebo, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious adverse effects (bleeding or seizures)</p> <p> </p> <p>Yes or no</p> <p>Follow‐up: at 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> —</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1154<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>5,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ginkgo biloba may result in little to no difference in the risk of serious adverse effects (bleeding or seizures), with zero cases reported in either group. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Zero events in the placebo group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Zero events in the Ginkgo biloba group</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus loudness</p> <p> </p> <p>Assessed with: audiometric loudness matching</p> <p>Follow‐up: at 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus loudness was 0.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 4 lower<br/>(13.33 lower to 5.33 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>3,4,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may result in little to no difference in tinnitus loudness compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> <p> </p> <p>Assessed with: GHSI (range: 0 to 100)</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life at 3 months was 2.52</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.58 lower<br/>(4.67 lower to 3.51 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>3,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ginkgo biloba may result in little to no difference in quality of life compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Other adverse effects (gastrointestinal upset, headache, allergic reaction)</p> <p> </p> <p>Yes or no</p> <p>Follow‐up: at 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/>(0.52 to 1.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1175<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>3,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ginkgo biloba may not increase the frequency of other adverse effects (gastrointestinal upset, headache, allergic reaction) compared to placebo. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/>(21 to 66) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>GHSI:</b> Glasgow Health Status Inventory; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>THI:</b> Tinnitus Handicap Inventory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One of the two studies omitted primary outcome data, and had dropout without reason; downgraded by 0.5 level for study limitations. <br/><sup>2</sup>Only people over the age of 60 are included in this body of evidence; downgraded by 0.5 level for indirectness.<br/><sup>3</sup>Wide confidence interval around the point estimate; small sample size; downgraded by 1 level for imprecision. <br/><sup>4</sup>Only a small proportion of the included studies reported on this critical outcome: publication bias is suspected; downgraded by 1 level for publication bias. <br/><sup>5</sup>Some of the studies have multiple domains of unclear or high risk of bias; downgraded by 1 level for study limitations.<br/><sup>6</sup>There are no data regarding the primary outcome measure for 14 participants in the intervention group and 12 participants in the control group at 12 weeks. Dropout is not explained. Almost all of the bias domains are rated as either unclear or high risk; downgraded by 1 level for study limitations. <br/><sup>7</sup>Zero events in either group; downgraded by 1 level for imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Ginkgo biloba compared to placebo for tinnitus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013514-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gingko biloba with concurrent intervention versus concurrent intervention only</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Gingko biloba with concurrent intervention versus concurrent intervention only</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> adults with tinnitus<br/><b>Setting: </b> audiology centre in Brazil<br/><b>Intervention:</b> Ginkgo biloba plus hearing aids<br/><b>Comparison:</b> hearing aids </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with hearing aids</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with Ginkgo biloba plus hearing aids</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus symptom severity</p> <p> </p> <p>Assessed with: THI (range: 0 to 100)</p> <p>Follow‐up: at 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus symptom severity at 3 months was ‐40</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.5 higher<br/>(2.83 higher to 12.17 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When Ginkgo biloba was used in combination with hearing aids, the reduction in tinnitus symptom severity at 3 months was not as great as when hearing aids were used alone, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse effects (bleeding or seizures)</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not report serious adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus loudness</p> <p> </p> <p>Assessed with: 10‐point VAS (range: 0 to 10)</p> <p>Follow‐up: at 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tinnitus loudness at 3 months was ‐3.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1 higher<br/>(0.52 higher to 1.48 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>When Ginkgo biloba was used in combination with hearing aids, the reduction in tinnitus loudness at 3 months was not as great as when hearing aids were used alone, but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not include measures of health‐related quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse effects (gastrointestinal upset, headache, allergic reaction)</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>The study did not reported adverse effects.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>SD:</b> standard deviation; <b>THI:</b> Tinnitus Handicap Inventory; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Not downgraded for indirectness, but it is worth noting that the study only included adult participants (mean age 56.3 years, SD 16.8 years).<br/><sup>2</sup>Very small sample size, below the requirement for optimal information size; downgraded by two levels for imprecision.<br/><sup>3</sup>Downgraded by one level for study limitations (high risk of bias) due to the lack of blinding during the conduct of the trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gingko biloba with concurrent intervention versus concurrent intervention only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013514-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of questionnaires measuring tinnitus symptom severity</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement instrument (author, year)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of items and subscales</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Internal consistency (Cronbach’s alpha for global<br/>score)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Functional Index (<a href="./references#CD013514-bbs2-0107" title="MeikleMB , HenryJA , GriestSE , StewartBJ , AbramsHB , McArdleR , et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear and Hearing2012;33:153-76.">Meikle 2012</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 items, 8 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.97</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Handicap Inventory (<a href="./references#CD013514-bbs2-0116" title="NewmanCW , JacobsonGP , SpitzerJB . Development of the tinnitus handicap inventory. Archives of Otolaryngology--Head and Neck Surgery1996;122:143-8.">Newman 1996</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 items, 3 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.93</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Handicap Questionnaire (<a href="./references#CD013514-bbs2-0097" title="KukFK , TylerRS , RussellD , JordanH . The psychometric properties of a tinnitus handicap questionnaire. Ear and Hearing1990;11:434-45.">Kuk 1990</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 items, 3 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.94</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Questionnaire (<a href="./references#CD013514-bbs2-0074" title="HallamRS . Manual of the Tinnitus Questionnaire (TQ). London: The Psychological Corporation, Brace &amp; Co, 1996.">Hallam 1996</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52 items, 5 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.94</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Reaction Questionnaire (<a href="./references#CD013514-bbs2-0155" title="WilsonPH , HenryJ , BowenM , HaralambousG . Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. Journal of Speech and Hearing Research1991;34:197-201.">Wilson 1991</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 items, 4 subscales</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a = 0.96</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tinnitus Severity Scale (<a href="./references#CD013514-bbs2-0144" title="SweetowRW , LevyMC . Tinnitus severity scaling for diagnostic/therapeutic usage. Hearing Instruments1990;41:20-1.">Sweetow 1990</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 items</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Examples of questionnaires measuring tinnitus symptom severity</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/full#CD013514-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013514-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Ginkgo biloba versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Tinnitus symptom severity (THI) at 3 to 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.35 [‐8.26, 5.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Serious adverse effects at 3 months (yes or no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Tinnitus loudness measured by audiometric loudness matching at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.00 [‐13.33, 5.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Health‐related quality of life at 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐4.67, 3.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Other adverse effects at 3 months (yes or no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.52, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Ginkgo biloba versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013514-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Gingko biloba with concurrent intervention versus concurrent intervention only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Tinnitus symptom severity (THI) at 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.50 [2.83, 12.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Tinnitus loudness (VAS) at 3 months (range 0 to 10) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.52, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Gingko biloba with concurrent intervention versus concurrent intervention only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013514.pub2/references#CD013514-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013514.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD013514-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD013514-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013514-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013514-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013514-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD013514-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013514-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013514-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013514-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013514-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013514-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013514\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013514\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013514\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013514\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013514\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013514.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013514.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013514.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013514.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013514.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714775985"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013514.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714775989"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013514.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d76edacc9937d',t:'MTc0MDcxNDc3Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 